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Biogenesis of Lysosome-related Organelles Complex 1 (BLOC-1) is a multimeric protein 
complex composed of eight subunits and involved in the intracellular trafficking of integral 
membrane proteins from early endosomes to lysosomes and lysosome-related organelles. The 
overall goal of this dissertation was to characterize BLOC-1 in the mouse brain and in vitro. 
Previous behavioral and electrophysiological studies of BLOC-1-deficient mice had suggested 
that BLOC-1 has a physiological function in the brain. The BLOC-1-deficient mouse brain was 
analyzed at postnatal day (P)1 and the brains of BLOC-1-deficient mice displayed subtle 
cytoarchitectural abnormalities specific to the hippocampus. Previous in vitro studies have 
shown that BLOC-1-deficient neurons have abnormalities in the development of their neurites. 
The brains from wild-type and BLOC-1-deficient mice were analyzed at P60, using the Golgi 
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method. BLOC-1-deficient neurons from some of the hippocampal neurons had defects in their 
dendritic arborization. Two of the BLOC-1 subunits, dysbindin and pallidin, have alternatively 
spliced variants that are expressed in brain. In addition to these subunit variants, the genomes of 
humans and other mammals contain an uncharacterized gene encoding a paralog of the 
cappuccino subunit. Some of the alternative subunits were found to replace the full-length form 
and form a stable complex with the other BLOC-1 subunits. BLOC-1 is well described to have a 
physical interaction with another multimeric protein complex, Adaptor Protein (AP)-3. The 
minimal region within dysbindin to bind AP-3 was delineated and critical residues were 
identified. 
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CHAPTER 1 
INTRODUCTION 
!  1
BLOC-1 
 Biogenesis of Lysosome-related Organelles Complex 1 (BLOC-1) is a multimeric protein 
complex composed of eight subunits. The first subunits identified as part of this complex were 
pallidin and muted, followed few years later by cappuccino and dysbindin [1-4]. Mutant mouse 
models for these four subunits are available and arose from spontaneous mutations [4-7]. The 
other four subunits of BLOC-1 were identified by mass spectrometry of the purified complex [8]. 
It has been proposed that BLOC-1 has a role in the biogenesis of lysosome-related organelles 
(LROs) based on the presence of abnormal LROs, such as melanosomes and platelet dense 
granules in the pallid and muted mutant mice [1,2]. LROs are cell-type specific, membrane-
bound compartments, which share common characteristics with lysosomes such as low lumenal 
pH and presence of lysosome-associated membrane proteins (reviewed in [9]). Later, BLOC-1 
was reported to be involved in the intracellular trafficking of integral membrane proteins from 
early endosomes to lysosomes and LROs in primary melanocytes [10], immortalized 
melanocytes [11], and fibroblasts [10,12], but the exact mechanism was and is still largely 
unknown. More recently, because BLOC-1 was shown to form a flexible linear chain with a 
substantial bend [13], and localize to tubular endosomes [10], it was investigated whether 
BLOC-1 could act as molecular scaffold for the formation of tubules. It was found that BLOC-1 
plays a role in the formation of recycling endosomes from sorting endosomes by interacting with 
the kinesin KIF13A and stabilizing the interaction between KIF13A and a phospholipid binding 
protein, Annexin A2 [14].  
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Hermansky-Pudlak Syndrome 
 In humans, mutations in some BLOC-1 subunits are associated with Hermansky-Pudlak 
syndrome (HPS), a rare autosomal recessive disorder [7,15-17], which was first characterized by 
two Czech physicians in 1959 [18]. Two patients were characterized to have seemingly unrelated 
symptoms of oculocutaneous albinism, prolong bleeding and lung abnormalities [18]. These 
symptoms were later attributed to defective LROs, i.e. melanosomes, and platelet-dense granules 
(reviewed in [19]). Since the first description of HPS, nine other types of HPS have been 
reported (reviewed in [20]). Three of which, HPS types, HPS-7, HPS-8, and HPS-9, have 
mutations in the BLOC-1 subunits, dysbindin [7,17], BLOS3 [15], and pallidin [16], 
respectively. The other HPS types were described to have mutations in other protein complexes 
also involved in the biogenesis of LROs. Analysis of the HPS affected individuals and mutant 
mice, with HPS-like phenotypes led to the identification of four complexes (AP-3, BLOC-1, 
BLOC-2, and BLOC-3), all of which are involved in the biogenesis of LROs (reviewed in [21]). 
  
BLOC-1 in Brain 
 The gene encoding one of the BLOC-1 subunits, DTNBP1, has also been associated with 
another disorder, schizophrenia. Schizophrenia is a psychiatric disorder with a 
neurodevelopmental origin and is estimated to affect more than 25 million people worldwide, 
and is predominant in males (reviewed in [22]). The estimated heritability is almost 80%, but no 
single gene with strong effect size is known. In a systematic linkage-disequilbrium mapping 
study across a previously linked schizophrenia susceptibility region, single nucleotide 
polymorphisms (SNPs) within the dysbindin-encoding gene, DTNBP1, were found associated 
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with increased risk of developing schizophrenia in an Irish population [23]. As a result, a number 
of studies followed to replicate this association in different populations, although with mixed 
results. According to the Schizophrenia Research Forum website, www.szgene.org, there have 
been 37 case-control studies and 15 family-based studies, in populations from 22 different 
countries. Twenty-two studies found a positive association and thirty studies found no 
association. Even among the studies that found a positive association, the specific markers and 
haplotypes reported in DTNBP1 reported to increase risk of developing schizophrenia were 
found to be inconsistent between studies (reviewed in [24]). Different meta-analyses have been 
done to deal with the issues of inconsistent use of SNPs [25] and to integrate the genetics studies 
with functional studies from humans and animal models [26], and the conclusion was that 
DTNBP1 was still a top candidate. Additionally, the protein levels of dysbindin were decreased 
in the postmortem brains of patients with schizophrenia [27,28]. Despite all these initial studies 
supporting the association between DTNBP1 and schizophrenia, to date, no genome-wide 
association study (GWAS) has found genome-wide significance for a DTNBP1 susceptibility 
variant. Additionally, no neuropsychiatric phenotypes have been reported in individuals with 
HPS caused by mutations in DTNBP1 [17]. It should be noted that DTNBP1 is one of 25 genes 
once considered strong candidates for schizophrenia that leading researchers in schizophrenia no 
longer consider to be so [29]. 
 Although the genetic association between DTNBP1 and schizophrenia has not panned 
out, ironically, studies using the sandy mice, which carries an in-frame deletion in the dysbindin-
encoding gene, have shown behavioral and electrophysiological abnormalities. Because the 
mutation in the Dtnbp1 gene in the sandy mouse arose spontaneously in the DBA/2J mouse 
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strain [7], initial studies were carried out in this background [30-33]. However, the DBA/2J 
mouse strain itself is known to have electrophysiological and behavior abnormalities [34], and 
for this reason, the sandy allele was transferred into the C57BL/6J background [35-38]. In the 
new background, only certain abnormalities previously observed were still consistently seen in 
the sandy mice (reviewed in [35]), suggesting a role for dysbindin in brain function. Moreover it 
is worthy to mention that behavioral and electrophysiological phenotypes described in the sandy 
mouse were detected in both homozygous and heterozygous mutants. Since the sandy mouse has 
an in-frame deletion in the gene encoding dysbindin, it was suggested that it may not be a true 
null, and express an abnormal form of dysbindin, leading to a semi-dominant or dominant allele 
for some of the behavioral or electrophysiological phenotypes (reviewed in [35]).  
 In my work, I studied the function of BLOC-1 deficient mouse, namely, the pallid mouse, 
which carries a non-sense mutation in the Bloc1s6 gene encoding pallidin [5]. The transcript 
levels of Bloc1s6 have been shown to be drastically reduced due to nonsense-mediated mRNA 
decay, and subsequently the protein it encodes is undetectable by immunoblot [3]. It was later 
described that the lack of pallidin in the pallid mouse leads to destabilization of BLOC-1 and 
reduced steady-state protein levels of the other BLOC-1 subunits [1], essentially making the 
pallid mouse not only a null for pallidin, but also for BLOC-1. Thus, this mouse is a good model 
to study the effects of lack of BLOC-1.  
 The behavior and electrophysiological analyses mentioned above were all carried out in 
adult mice and it was assumed that the abnormalities observed were due to absences of BLOC-1 
in an otherwise normally developed brain. Analysis of the protein levels of the BLOC-1 subunits, 
dysbindin and pallidin, showed that BLOC-1 in the brain is expressed at higher levels during 
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embryonic and early postnatal periods than in young adulthood, suggesting that BLOC-1 might 
play a role during brain development [40]. However, it is unclear how BLOC-1 deficiency 
affects the developing brain. This issue will be discussed in Chapters 2 and 3 of this dissertation. 
One of the reported functions of BLOC-1 is in the neurites outgrowth. Cultured hippocampal 
neurons from pallid and sandy mice were shown to have deficits in neurite outgrowth [40,41]. 
Additionally, RNAi-mediated knockdown of dysbindin in cultured hippocampal neurons from 
rats affected proper development of their dendritic spines [42]. Since these analyses were done in 
vitro, I set out to determine whether lack of BLOC-1 affects neuronal morphology in the 
hippocampus, which will be discussed in Chapter 4. 
BLOC-1 and alternative subunits 
 Analysis of some of the BLOC-1 subunits in the brain also led to the discovery that 
different splice variants of two of the BLOC-1 subunits seemed to be expressed in the brain. One 
study examined the expression pattern of dysbindin splice variants in human postmortem brains 
and reported that the splice variants were expressed in different areas of the brain in a isoform-
dependent manner [28]. A second study showed that in human brains, only the mRNA of a splice 
variant of pallidin was expressed [16]. In addition to these variants, the cappuccino subunit was 
reported to have a paralog encoded by the gene BCAS4 [4]. Proteomic analysis of the BCAS4 
protein showed that this protein interacts with all BLOC-1 subunits except cappuccino [43]. 
Altogether these findings led me to ask the following question: can these alternative splice 
variants and paralogs replace the full-length subunits to form a complex like BLOC-1? This 
question will be addressed in Chapter 5.  
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BLOC-1 and AP-3 
 Adaptor Protein (AP)-3 is a heterotetrameric protein complex composed of four subunits, 
δ, β3, µ3, and σ3 [44]. Various animal models with mutations in AP-3 have helped illuminate the 
function of this complex (reviewed in [45]). Two mouse models (mocha [46] and pearl [47]) and 
two patients (HPS-2 [48]), with mutations in the genes encoding AP-3 subunits present with 
hypopigmentation and prolonged bleeding, suggesting that AP-3 plays a role in the biogenesis of 
lysosome-related organelles. Analysis of cultured cells from AP-3-deficient mammals have 
shown major missorting of lysosomal membrane proteins [48]. Because of the similar 
characteristics of BLOC-1 and AP-3 mutants, it was hypothesized that these two complexes 
worked in the same machinery that controls protein sorting from endosomes to lysosomes and 
LROs. In fact, a physical interaction between BLOC-1 and AP-3 has been well characterized in 
different tissues and cell lines [10,50-53]. However, the critical residues for this interaction are 
not known and will be addressed in Chapter 6. 
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CHAPTER 2 
Morphological analysis of BLOC-1-deficient mouse brain 
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ABSTRACT 
Previous behavioral and electrophysiological studies of BLOC-1-deficient mice had 
suggested that BLOC-1 has a physiological function in the brain. In this chapter, the 
morphology of the BLOC-1-deficient brain was analyzed in mice at different 
developmental ages. I have found that at postnatal day 1 the brains of BLOC-1-deficient 
male, but not females, displayed decreased weight and cytoarchitectural abnormalities 
specific to the hippocampus.  
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INTRODUCTION 
 After the initial studies that linked single nucleotide polymorphisms in DTNBP1 
with schizophrenia, several behavioral and electrophysiological studies were carried out 
using mouse models to test whether dysbindin has a physiological function in brain. Most 
studies were done using the BLOC-1-deficient sandy mouse, which carries a mutation in 
the Dtnbp1 gene.  Electrophysiological analyses conducted in the sandy mice found that 
dysbindin deficiencies caused both pre- and postsynaptic abnormalities [4-9]. These mice 
were also reported to have increased dopamine release and over-expression of D2 
dopamine receptors at the cell surface [10,11]. Multiple behavioral studies consistently 
observed that sandy mice have impaired memory [8,9,13]. As mentioned in the previous 
chapter, dysbindin was found to be part of BLOC-1 in mouse liver [1] and it was later 
determined that its longest form is part of BLOC-1 in brain [2]. Consistent with this idea, 
impaired memory was also reported the pallid mice, which carry a mutation in another 
subunit of BLOC-1 [14]. From the behavior and electrophysiological studies, it is evident 
that BLOC-1 has a physiological role in brain.  
 In the previously mentioned studies, it was predominantly assumed that the 
behavioral and electrophysiological phenotypes observed in the sandy and pallid mice 
were due to deficiency of BLOC-1 in an otherwise normally developing brain. However, 
it was also reported that protein expression levels of some of the BLOC-1 subunits 
(dysbindin and pallidin) in the cerebral cortex, hippocampus, and cerebellum were higher 
during embryonic and early postnatal periods than in young adulthood, suggesting that 
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BLOC-1 might play a role during brain development [2]. Hence, to examine the possible 
role of BLOC-1 during brain development, I have analyzed the gross morphology of the 
BLOC-1-deficient mouse brain. In particular, I examined the brain wet-weight at various 
postnatal ages and then the cytohistopathology of two brain regions (cerebral cortex and 
hippocampus) of relevance to the behavioral defects shown in BLOC-1-deficient mice.  
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EXPERIMENTAL PROCEDURES 
Animals 
The BLOC-1-deficient mutant “pallid” mice, B6.Cg-Bloc1s6pa/J, and the “wild type” control 
strain (WT), C57BL/6J, were from our breeding colony maintained at the University of 
California, Los Angeles (UCLA). Euthanasia prior to tissue dissection was performed in 
accordance to procedures approved by the UCLA Chancellor’s Animal Research Committee. 
Brain weight 
The whole brains of WT and pallid male mice at three difference ages [postnatal day (P)1, P14, 
and P45] as well as from P1 pallid females and age-matching WT, were dissected out and rapidly 
weighted on an analytical balance. A minimum of five animals was used for each age per gender 
per genotype. For the P1 WT and pallid males and females, the overall body mass was also 
measured before euthanasia. 
Specimen preparation for Nissl Staining 
Whole brains of P1 WT and pallid male (5 animals per genotype) and female (5 animals per 
genotype) mice were rapidly dissected out and fixed overnight in 4% (w/v) paraformaldehyde 
(PFA) at 4°C. P45 WT and pallid male mice (4 animals per genotype) were anesthetized with 
isoflurane and transcardially perfused with saline solution (NaCl 0.15 M) followed by phosphate 
buffered saline containing 4% (w/v) PFA. The brains were rapidly dissected out and post-fixed 
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overnight in 4% (w/v) PFA at 4°C and then cryoprotected in 15% (w/v) sucrose. Sequential 
Coronal sections (40 µm) cut on a Lecia cryostat were collected. 
Nissl staining 
The coronal sections were processed with the following protocol: sections were dehydrated and 
rehydrated using increasing and decreasing concentration of ethanol (70% (v/v) ethanol for 5 
mins; 95% (v/v) ethanol for 5 mins; absolute ethanol for 5 mins; 95% (v/v) ethanol for 5 mins; 
70% (v/v) ethanol for 5 mins; 50% (v/v) ethanol for 5 mins). After rinsing in water, sections were 
incubated with cresyl violet acetate stain [1% (w/v) cresyl violet in acetate buffer] for 5 mins. 
After rinsing in water three times, sections were dehydrated (70% (v/v) ethanol for 5 mins; 95% 
(v/v) ethanol for 5 mins) and placed in the differentiation solution [6 drops of glacial acetic acid 
in 100 mL of 95% (v/v) ethanol] for up to 1 hour, until the structures of interest were clearly 
defined. After incubation in 95% (v/v) ethanol for 1 min, absolute ethanol for 1 min, and xylene 
for 5 mins three times, coverslips were then mounted using DPX (distyrene plasticizer toluene-
xylene; Sigma) mounting medium. 
Imaging/Analysis 
Images of Nissl-stained sections were acquired on a Zeiss Axioskop microscope with an 
Axiocam using the AxioVision software (Zeiss). The cross-sectional area and perimeter of the 
hippocampus, and the thickness of the cerebral cortex (layers I-VI), both in rostral and caudal 
sections were measured from the images of the stained sections using the Axiovision software by 
two independent investigators masked to the genotype and age of the animals. The cell density of 
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the Cornus Ammonis (CA)1 region was analyzed by measuring the staining intensity of the 
Nissl-stained sections using the National Institutes of Health Image ImageJ Software ( http://
rsb.info.nih.gov/ij/) [15]. We determined that staining intensity using the “profile plot analysis” 
as follow: a grid was over-imposed on each image using the “Grid Setting” (“Area Per Point” set 
to 16000 pixel^2) as shown in blue in Figure 2.2, and then three identical rectangular boxes were 
drawn with the following criteria: width of the box was the same as that of one column of the 
grid, while the height of the box encompassed the cell layer of the hippocampus (magenta box in 
figure 2.2) about two of the grid squares. A rectangular box was set in the third, fifth, and seventh 
columns of the grid at fixed distance from the lateral ventricle. The “profile plot analysis” was 
then performed for each box. This analysis measures the average pixel intensity per row of pixels 
within the matrix of the rectangular box. Values from the three plots were averaged to produce an 
average plot per brain section, and 8-12 sections were analyzed per animal. A polynomial curve 
(order: 6th) was fit to each average plot, the peaks of the average plots per section were aligned to 
then calculate a single averaged plot per animal. A total of five P1 animals per genotype per 
gender were analyzed and a total of four P45 animals per genotype were analyzed. 
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RESULTS 
The wet-weight of pallid male brains is less than that of the WT male brains at P1 
 As a first crude approximation, brain wet-weight was measured to determine if lack of 
BLOC-1 affects brain development in mice. At P1, the pallid male brains displayed a significant 
decrease in wet-weight (10%) as compared to WT male brains and the difference was not due to 
differences in body weight (Fig. 2.1). More importantly, there was no significant difference in the 
brain wet-weight of female mice at P1. In addition, the brain wet-weight of older (P14 and P45) 
pallid male mice were not different from age-matching WT (Fig. 2.1). To identify if such 
differences were due to abnormalities in a specific brain region, individual brain areas (forebrain, 
hindbrain, and cerebellum) were dissected and weighed. However, I was unable to obtain a clear 
result. Because of the brain size, the dissection had to be done in PBS, under a stereoscope, and 
as a result, the samples had differing amounts of PBS, producing a high variability. 
Anomalous distribution of the hippocampal cell layer in pallid male mice at P1 
 Next, the cross-sectional area and perimeter of the hippocampus as well as the thickness 
of the cerebral cortex (rostral and caudal) were measured in Nissl-stained brain sections to 
identify any gross morphological differences. No differences were seen in either brain regions 
between pallid and WT male mice at either P1 or P45 (Table 2.1). However, an anomalous 
distribution was observed in the CA1 cell layer of P1 pallid males. More in particular, the cell 
bodies were not as compact as in the WT hippocampus, but appeared dispersed, covering a wider 
area (Fig. 2.2A-D). This phenotype was less evident in pallid females, in which the distribution 
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of cell bodies was closer to that of the WT (Fig. 2.2E,F). To quantify cell body dispersion, 
staining intensity of Nissl-stained sections was measured across the cell layer. The pallid males 
displayed a signficantly wider cell layer along with a decrease in staining intensity compared to 
the WT (Fig. 2.3A). Even though the P1 pallid females showed a slightly wider peak, this 
differences was not as much as the pallid males, and there was no apparent differences in levels 
of staining intensity compared to the plot of WT cell layer (Fig. 2.3B). Lastly, the cell layer of 
the P45 WT and pallid males had no differences (Fig. 2.3C). These findings suggest that the 
hippocampal cytoarchitecture in females is less affected by lack of BLOC-1 compared to males 
and in the latter, this phenotype is recovered with time. 
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DISCUSSION 
  
 Analysis of the BLOC-1-deficient brains at early postnatal ages showed clear 
abnormalities in males supporting the hypothesis that BLOC-1 has a function during brain 
development and, more importantly suggesting that its deficiency has sexual dimorphic effects. 
At P1, BLOC-1-deficient male brains weighed less than WT male brains and displayed an 
anomalous cell distribution in CA1. Cell distribution in CA1 appeared to be dispersed and lack 
compaction. Such phenomenon could be due to the lack of BLOC-1 interfering with cell 
migration, delayed or slower, and mis-positioning of the neurons or changes in cell number. This 
question will be further discussed in Chapter 3. 
 Interestingly, the abnormalities observed in P1 BLOC-1-deficient male mice were less 
pronounced in the BLOC-1-deficient P1 female mice, suggesting that they are somehow 
“protected” from the deleterious effects of BLOC-1 deficiency on brain development.  It has 
been well documented that some neurological and developmental neuropsychiatric disorders 
(Alzheimer’s disease, multiple sclerosis, schizophrenia) present sex differences, either in disease 
prevalence or in the presentation of the symptoms, where they may appear earlier in one gender 
or with greater severity (reviewed in reference 16). Although the mechanism is not well 
understood, experimental and clinical evidence suggests that estrogen may have a protective 
effect on the brain atrophy and dysfunction (reviewed in references 17,18). Thus, it is possible 
that these similar neuroprotective effects are acting in the BLOC-1-deficient female brain. Lastly,  
since the abnormalities seen at P1 were absent at later postnatal ages, we could speculate that a 
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possible compensatory mechanism(s) occurs, and further work is required to identify these 
underlying compensatory mechanism(s) and or factors. 
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Table 2.1 No differences in cerebral cortical thickness and hippocampal area 
between wild-type and pallid brains at postnatal day (P)1 and P45. Nissl-stained 
wild-type (WT) and pallid (Pa) brain sections were used to measure cerebral cortical 
thickness (rostral and caudal), hippocampal area and hippocampal perimeter. 
Measurement values are in their corresponding units as labeled and the errors are the 
SEM. Statistical significance was assessed using a two-way ANOVA (Analysis of 
Variance) model. 
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Rostral Cerebral Cortex 
Thickness (µm) Genotype Age 
Interaction Effect 
(genotype x age) 
P1 
WT 2228 ± 92 ; n=5 
F = 2.02; 
P=0.177 
F = 520; 
P<0.0001 
F = 0.23; P=0.635 
Pa 2072 ± 81 ; n=5 
P45 
WT 4060 ± 72 ; n=4 
Pa 3983 ± 64 ; n=4 
      
  
Caudal Cerebral Cortex 
Thickness (µm)    
P1 
WT 1849 ± 66 ; n=5 
F = 0.25; 
P=0.625 
F = 298; 
P<0.0001 
F = 1.13; P=0.305 
Pa 1815 ± 31; n=5 
P45 
WT 2838 ± 89 ; n=4 
Pa 2933 ± 47 ; n=4 
      
  
Hippocampal  
Perimeter (µm) 
   
P1 
WT 12401 ± 332 ; n=5 
F = 0.68; 
P=0.421 
F = 699; 
P<0.0001 
F = 0.47; P=0.504 
Pa 12034 ± 128 ; n=5 
P45 
WT 18643 ± 212 ; n=4  
Pa 18609 ± 219 ; n=4 
      
  
Hippocampal  
Area (mm2)    
P1 
WT 7.582 ± 0.53 ; n=5 
F = 0.07; 
P=0.788 
F = 841; 
P<0.0001 
F = 3.18; P=0.096 
Pa 8.213 ± 0.14 ; n=5 
P45 
WT 20.45 ± 0.53 ; n=4 
Pa 19.59 ± 0.34 ; n=4 
 Figure 2.1 Pallid male mice have smaller brains than wild-type mice at postnatal 
day (P)1. (A) Whole brains of male and female wild-type (WT) and pallid (Pa) mice at 
P1 were dissected and weighed. Each dot represents the brain wet-weight of one animal 
and each line represents the mean. (B) Before dissecting the brains from the bodies, the 
whole body of the P1 mice was weighed. Each dot represents the body weight of one 
animal and each line represents the mean. (C) The brain wet-weight of each animal was 
divided by its body weight to calculate the brain to body weight ratio. Each dot represents 
the brain weight to body weight ratio of one animal and each line represents the mean. 
(D) Whole-wet brains of male WT and Pa mice were also dissected and measured in 
older mice. Bars and error bars represent the mean ± SEM of the brain wet-weight at P1 
(WT: n=22, Pa: n=23), P14 (WT: n=13, Pa: n=11) and P45 (WT: n=7, Pa: n=6). 
Statistical significance was assessed using a one-way ANOVA (Analysis of Variance) 
model followed by Bonferroni’s multiple comparison tests. **p<0.01, *p<0.05, ns, not 
significant. 
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Figure 2.2 Cellular arrangement of the hippocampal cell layer is abnormal in the 
pallid mice at postnatal day (P)1. Nissl-stained male wild-type (WT) (A) and pallid  (B) 
hippocampi. The hippocampal cell layer in the P1 male pallid mouse appears to have a 
diffused cellular distribution (arrows) compared to that of P1 male WT mouse 
(arrowheads), particularly in the cornus ammonis (CA)1 area. DG, dentate gyrus. The 
black boxes in panels A and B indicate regions shown at higher magnification in panels C 
and D respectively. CL, cell layer. (E,F) High magnification of the CA1 area in female 
WT and pallid hippocampi. In panels C-F, blue lines represent the grid and magenta lines 
represent the rectangular boxes used for the analysis of the CA1 cell layer as described 
under Experimental Procedures. Scale bar, 100µm.  
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CHAPTER 3 
BLOC-1 deficiency hinders radial glial cells in the hippocampus of 
newborn mice  
!  34
ABSTRACT 
Neural cell maturation is a timely process tightly regulated, which terminates with the cell 
migrating to its final location and becoming fully differentiated. In this chapter, I investigated 
whether the atypical cell distribution observed in BLOC-1 deficient CA1 of hippocampus at 
postnatal day 1 was due to an abnormality in some of the cells and factors involved in migration. 
The protein levels of GLAST and nestin, which are markers for radial glia, a cell type critically 
involved in neuronal migration, were greatly reduced in pallid male mice, and fewer fiber tracts 
could be seen in male pallid CA1. This phenotype was much less severe in age-matching pallid 
females. In agreement with lack of a well-assembled radial glia scaffold, the expression pattern 
of immature neuronal markers in pallid CA1 was also in disarray, while the protein levels were 
unaltered. These results suggest that BLOC-1-deficient immature neurons are mal-positioned due 
to the defects in the fiber tracts of radial glial cells. 
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INTRODUCTION 
 In mouse, hippocampal development begins around embryonic day (E)12.5, when the 
dorsal telecephalnon gives rise to three areas: the hippocampal neuroepithelium (HNE), dentate 
neuroepithelium (DNE), and cortical hem (CH). Cajal Retzinus cells are located along the pial 
side of the HNE, which later develops into the CA1-3 areas. These cells secrete a large 
glycoprotein, called reelin, which plays a critical role in the regulation of neuronal migration and 
positioning. At E14.5, radial glial cells appear in the ventricular zone of the HNE, and extend 
their processes toward CA1, forming the tracts along which pyramidal neurons will migrate to 
reach their final location. By E17.5, the development of the hippocampus is nearly complete. At 
this stage, pyramidal neurons born in the ventricular zone migrate along the processes of the 
radial glia, towards their location in the hippocampal areas. Cajal-Retzinus cells continue to be 
present and to secret reelin. By birth, most of the CA1 pyramidal neurons have migrated 
(reviewed in reference 1).  
 Perinatally, CA1-3 are composed of 6 to 10 rows of neuronal somata. However, this 
number decreases as hippocampal development progresses and eventually the cell layer has 2 to 
3 rows of cells [2]. It has been suggested that this change in thickness is unlikely to be a passive 
effect. Perinatal X-ray irradiation has been shown to preferential affect radial glia and cause an 
anomalous distribution of neuronal cell bodies in the hippocampal cell layer, suggesting that 
these cells also play role in the perinatal maturation and refinement of the cell layers [3]. Another 
factor that likely plays a pivotal role in this process is reelin. This glycoprotein is involved in the 
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maintenance of the radial glial scaffold and considered a stop signal for the migratory neurons. In 
its absence, the hippocampal cell layer has an unusual lamination and is malformed [2].  
 In the previous chapter, I reported that BLOC-1-deficient mice at postnatal day (P)1 
displayed an abnormal distribution of CA1 neurons. One possible explanation for this 
phenomenon stems from the proposed role of BLOC-1 in membrane biogenesis and secretion 
[4]. Thus, I hypothesize that BLOC-1 could interfere with the neuronal migration process, 
pathways, and players during which long processes need to be extended and “go and stop” 
signaling cues are released into the extracellular space. In line with this hypothesis, I analyzed 
the expression levels of radial glial markers as well as its morphology in BLOC-1-deficient 
hippocampi, and the protein levels of the different forms of reelin in comparison with wild-type 
(WT) mice. In addition, I analyzed the protein levels and expression pattern of several immature 
neuronal markers in BLOC-1-deficient hippocampi and compared to WT, to rule out that the 
observed effect could be cause by loss or “gain” of neurons. 
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EXPERIMENTAL PROCEDURES 
Animals 
Mouse strains were used maintained as previously described in chapter 2. 
Antibodies 
Primary antibodies were used at the following concentrations for immunohistochemistry (IHC) 
or western blot (WB): rabbit anti-α-Internexin (Millipore, Cat.# AB5354) IHC = 1:250, WB = 
1:500; rabbit anti-βIII-Tubulin (Covance, Clone: Tuj1) IHC = 1:200, WB = 1:10,000; rabbit anti-
doublecortin (Cell Signaling, Cat.# 4604) IHC = 1:300, WB = 1:1000; guinea pig anti-GLAST 
(Millipore, Cat.# AB1782) IHC = 1:250, WB = 1:1000; mouse anti-GLAST (Millipore, Clone: 
8C11.1); Mouse anti-nestin (BD Biosciences, Clone: Rat401) IHC = 1:100, WB = 1:1000; rabbit 
anti-reelin (Millipore, Clone: 142) WB = 1:1000; mouse anti-β-actin (Sigma, Clone: AC-15) WB 
= 1:10,000 
Immunohistochemistry 
The brains of P1 wild-type (WT) and pallid mice were rapidly dissected out, fixed overnight in 
4% (w/v) paraformaldehyde at 4°C, and then cryoprotected in 15% (w/v) sucrose. Coronal 
sections (40 µm) were cut on a Lecia cryostat Leica, collected sequentially. Sections (40 µm) 
were blocked for 1 h in carrier solution [1% BSA (w/v) and 0.3% (w/v) Triton X-100 in 
phosphate-buffered saline (PBS)] containing 20% (v/v) normal donkey serum then incubated for 
24h or 48h at 4°C with primary antibodies diluted in carrier solution  containing 5% (v/v) normal 
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donkey serum. Following incubation with primary antibodies, tissue sections were washed 3 
times for 10 min each with carrier solution, incubated with the appropriate secondary antibodies 
conjugated to Cy3 (Jackson ImmunoResearch Laboratories) or AlexaFluor 488 (Molecular 
Probes) diluted in carrier solution, and washed again 3 times for 10 min each in carrier solution. 
Tissue sections were mounted with Vectashield mounting medium with DAPI (4’-6-diamidino-2-
phenylinodole; Vector Laboratories). Immunostained sections were visualized and images taken 
on a Zeiss Axio Imager 2 microscope equipped with an AxioCam MRm and the ApoTome 
imaging system (Zeiss) using the Axiovision software. 
Immunoblot analysis  
Hippocampi from P1 WT and pallid mice were rapidly dissected and frozen. WT and pallid 
samples were prepared and run in pairs. Hippocampi were homogenized in lysis buffer [50 mM 
Tris-HCl (pH 7.5), 1% (w/v) Triton X-100, 0.25% (w/v) sodium deoxycholate, 0.1% (w/v) 
sodium dodecyl sulfate (SDS), 0.15 M NaCl, 1 mM EDTA] containing a protease inhibitor 
mixture consisting of 1 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride, 10 mg/l leupeptin, 5 mg/
l aprotinin and 1 mg/l pepstatin A, as previously reported [4]. Samples were incubated on ice for 
30 min. The crude extracts were then cleared by centrifugation for 10 min at 14,000 rpm. Total 
protein concentration of cleared extracts was estimated using the PierceTM BCA Protein Assay 
Kit (Thermo Fisher Scientific) with bovine serum albumin as a standard. Based on the resulting 
total protein concentrations of the samples, appropriate amounts of lysis buffer and SDS 
polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer [50 mM Tris-HCl, pH 6.8, 15.6 
g/l dithiothreitol, 0.1 g/l bromophenol blue, 4% (w/v) SDS, 12% (w/v) glycerol] were added in 
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order to equalize the total volume of all samples. Samples were then heated up at 95°C for 3 
mins, spun down, and stored at -80°C.  
Thirty µg of total proteins were resolved by SDS-PAGE on a 4–20% Tris-Glycine gel 
(Invitrogen). The proteins were transferred onto polyvinylidene difluoride membranes (BioRad) 
overnight (35 V) at 4°C in transfer buffer [25 mM Tris base, 192 mM glycine, 20% (v/v) 
methanol]. Equal protein loading was verified by Ponceau S solution (Sigma) reversible staining 
of the membranes. The membranes were incubated in blocking buffer [5% (w/v) non-fat dry milk 
and 0.5% (w/v) Tween® 20 in PBS] for at least 1 hour at room temperature. Membranes were 
then incubated overnight at 4°C with primary antibody diluted in blocking buffer. After washing 
3 times for 10 min in PBST (0.5% (w/v) Tween® 20 in PBS), then membranes were incubated 
for 30 min at room temperature with the appropriate HRP horseradish peroxidase-conjugated 
secondary antibodies (Cell Signaling) in blocking buffer, and again washed 3 times for 10 min in 
PBST. Protein bands were detected by chemiluminescence using the Thermo ScientificTM 
PierceTM ECL 2 Western Blotting Substrate or the Amersham ECL kit (GE Healthcare). For 
quantitative analysis of protein expression levels, enhanced chemiluminescence signals were 
captured on X-ray films, scanned at a resolution of 720 dots per inch and 8 bits per pixel, and 
digitally integrated using the National Institutes of Health ImageJ Software ( http://
rsb.info.nih.gov/ij/). For the comparison of relative protein levels, the mean pixel intensity was 
measured for each band using the same area for both WT and pallid samples lanes. The pixel 
intensity of the background was then subtracted from that of each sample band. Background-
corrected values of each sample were then divided by the background-correct values of the 
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respective β-actin. For each WT and pallid pair, the normalized values were divided by the 
normalized value of the WT. Because WT values were divide by itself, all WT values equaled 
one. Therefore, pallid ratios were analyzed using one sample t-test comparing pallid ratios to the 
theoretical value of one using GraphPad Prism 5.0b (GraphPad Software). 
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RESULTS 
Radial glia processes are disrupted in the male pallid hippocampus 
 In a normally developing murine brain, radial glia processes extend across the hippocampal 
cell layer and form a scaffold along which neurons migrate. To determine if the extension of 
these tracks was affected by the lack of BLOC-1, the expression of GLutamate ASpartate 
Transporter (GLAST), a marker of radial glia, was examined at P1. In the WT male 
hippocampus, the GLAST-positive radial glial processes were observed nicely aligned 
throughout the entire cell layer (Fig. 3.1A). In contrast, in the pallid male hippocampus, the 
immunoreactivity of GLAST was drastically reduced and the radial glia tracks almost completely 
absent (Fig. 3.1A). In the female hippocampus of WT and pallid mice, there was no apparent 
difference in immunostaining of GLAST (Fig. 3.1B) Next, the total protein levels of GLAST 
were measured by immunoblot. In males, the total protein levels of GLAST were significantly 
decreased in the pallid hippocampi compared to the WT hippocampi, and in the females, the 
protein levels of GLAST in pallid and WT hippocampi had no differences (Fig 3.2). These 
findings were further confirmed by using nestin, a marker for radial glia as well as neural 
progenitor cells. The immunoreactivity of nestin was also greatly reduced in the pallid male 
hippocampus and again the tracts of the radial glia were not visible (Fig 3.3A). No apparent 
differences in nestin expression was observed in the female hippocampus of WT and pallid mice 
(Fig. 3.3B).The total protein levels of nestin displayed a striking decrease in the pallid male, but 
not female hippocampi as compared to age-matching WT (Fig. 3.4) These results suggest that 
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lack of BLOC-1 elicits a weakening of the radial glia scaffold in male mice hampering 
hippocampal development. 
 Next, the expression of reelin was examined. This large extracellular protein is a crucial 
regulator of neuronal migration, and it is involved in stabilizing the radial glial scaffold. It is 
known that there are three cleavage sites on reelin, which produce multiple fragments with 
different molecular weights. Among them, the 180 kDa fragment is considered able to be 
excreted in the extracellular space and to diffuse far enough from the Cajal Retzius cell layer to 
regulate cell migration in the different layers. It is accepted that any change in its levels will 
greatly affect cell migration. The identity or role(s) of the even smaller fragments is still 
controversial. I used an antibody that detects the full-length 400 kDa, the 300 kDa, and the 180 
kDa forms and no differences were found in males or females pallid and WT (Fig. 3.5).   
Subtle alterations in the staining pattern of immature neuronal markers 
 Neurons are derived from neuroepithelial multiple potential progenitor cells, and they 
express markers at different developmental stages. The expression of some of these markers 
overlap and do no clearly define a maturation stage or a type of neuron, hence more than one 
marker must be used to thoroughly examine normal maldevelopment. The expression of 
doublecortin, a microtubule-associated protein expressed in neuroblasts and immature neurons, 
in P1 male and female pallid CA1 did not differ from that of gender or age-matching WT, 
although it seemed to be slightly decreased in pallid males (Fig 3.6A, arrows). The neuronal 
intermediate filament protein, α-internexin, is highly expressed during embryogenesis and in 
immature neurons. In male pallid hippocampus at P1, the α-internexin-positive neurons appeared 
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to be in disarray, particularly near the subiculum compared to those of matching age and gender 
WT (Fig. 3.7A arrows). Conversely, the organization of immature pallid females did not appear 
to be different from WT (Fig. 3.7B). This result suggests that the immature neurons are 
“malpositioned” in the male pallid hippocampus during early postnatal development. At this 
stage of maturation, immature neurons also express βIII-tubulin and as expected the layout of the 
CA1 neurons in pallid males appeared disorganized around the subiculum, although such effect 
was more subtle than seen with α-internexin (Fig 3.8A). In addition, some βIII-tubulin-positive 
neurons displayed a strong and more defined staining especially of a long leading process, 
characteristic of migrating neurons (Fig 3.8A, arrows). The expression pattern of βIII-tubulin did 
not show any abnormalities in pallid females (Fig 3.8B). The total protein levels of these 
immature neuronal markers, doublecortin (Fig. 3.9), α-internexin (Fig. 3.10), and  βIII-tubulin 
(Fig. 3.11), were not different between genotypes in both males and females at P1. 
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DISCUSSION 
 Here, I further investigated and characterized the abnormal cytoarchitecture observed in 
CA1 in P1 pallid males, but absent in females. Markers for immature neurons displayed normal 
total protein levels, but an atypical expression pattern in pallid males. This effect was 
accompanied by a dramatic reduction in the presence of radial glia tracts, as shown by the drastic 
decrease in GLAST and nestin immunoreactivity and total protein levels. These findings suggest 
that a weakening of the glial scaffold might be hampering or delaying neuronal migration to the 
cell layer of CA1 and causing the aberrant neuronal distribution seen in BLOC-1-deficient 
hippocampi early postnatally. This aberrant cyto-organization was not accompanied by changes 
in the protein levels of the different reelin forms. As shown in the previous chapter, these 
abnormalities were absent at a later postnatal age, P45, suggesting that not all the components of 
the signaling pathways involved in these process are disrupted by lack of BLOC-1, for instance 
reelin secretion into the extracellular space.  
 Although the functional role of BLOC-1 in the the central nervous system is not yet fully 
understood, our group and others have previously reported that BLOC-1 in brain may be 
involved in neurite elongation [4,6]. Although the mechanism is not fully understood, it has been 
suggested that impairment of the cargo delivery by BLOC-1 could disturb neurite outgrowth. 
Thus, it is plausible to speculate that lack of BLOC-1 also negatively affects the extension of the 
radial glia fibers. Further analysis is required to address this point. 
 As discussed in Chapter 2, the alternation in cell distribution seen in BLOC-1-deficient 
CA1 at P1 was absent in P45 pallid mice, suggesting that other pathways and players involved in 
cell migration are not affected and the phenotype is somehow compensated. For instance, protein 
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levels of reelin were not found to be different in pallid and WT. In addition, previous studies 
have demonstrated that mice lacking glutamate transporters GLAST, GLT1, and EAAC1, have 
seemingly normal brain development, suggesting that glutamate transporter subtypes may 
functionally compensate for one another during brain development [7,8,9]. Only in mice lacking 
two of the glutamate transporters (GLAST -/- and GLT1 -/-) displayed multiple brain defects 
[10]. Strikingly, one of the phenotypes reported in these double mutants is less densely packed 
pyramidal neurons in the hippocampus [10]. Thus, it could be that in BLOC-1-deficient brains, 
normal levels of reelin and other proteins, such as GLT1 and EAAC1, cooperate to rescue the P1 
phenotype, and although delayed, the neurons will eventually reach their final position or at least 
appear to. 
 The effects described above were absent or much less pronounced in BLOC-1-deficient 
females, further suggesting that BLOC-1-deficient females are protected from the effects of 
BLOC-1-deficiency. 
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 Figure 3.1 The expression of the radial glia marker, GLAST, is altered in postnatal 
day (P)1 male pallid CA1, but not in females. (A) Left panels, in wild-type (WT) CA1, 
radial glia processes were observed throughout the entire width of the CA1, while (right 
panels) pallid hippocampi displayed a dramatic decrease in GLAST immunopositive 
processes. (B) Right bottom panel, pallid females were less affected than males by lack of 
BLOC-1. Well organized GLAST- positive radial glia fibers could be seen across CA1 in 
pallid females similarly to WT females and males. Sections (40 µm) from male mice in A 
were stained using a guinea pig polyclonal anti-GLAST antibody, whereas, those from 
females in B, using a mouse monoclonal anti-GLAST. White boxes in top panels indicate 
regions shown at higher magnification. Left and right panels in B are representative 
higher magnification images taken as shown by the white boxed area in A. CA: Cornus 
Ammonis; DG: dentate gyrus. Scale bars, 100 µm. 
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 Figure 3.2 GLAST total protein levels are drastically reduced in the male pallid 
hippocampi at postnatal day (P)1. (A) Representative immunoblots of hippocampal 
extracts from both males and females wild-type (WT) and pallid mice at P1. β-actin was 
used as a loading control. (B) Each band was analyzed by densitometry corrected for 
background, normalized to β-actin levels. Data are shown as the mean ± S.E.M. of the 
ratio of each pallid and its respective WT, n = 5 animals per genotype per gender. 
Statistical significance was assessed using a one-sample t-test. **p<0.01, ns, not 
significant. 
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 Figure 3.3 Nestin expression in CA1 is impacted by lack of BLOC-1 at postnatal day 
(P)1 in pallid males, but not females. (A) Left panels, in wild-type (WT) CA1, radial 
glia processes, immunopositive for nestin were observed throughout the entire width of 
the CA1, whilst (right panels) pallid hippocampi displayed a drastic decrease in nestin 
immunopositive processes. (B) Right panel, pallid females were less affected than males 
by lack of BLOC-1. Well organized nestin-positive radial glia fibers could be seen across 
CA1 in pallid females similarly to WT females and males. Sections (40 µm) from male 
and female mice in A and B were stained using a mouse monoclonal anti-nestin antibody. 
White boxes indicate regions shown at higher magnification. Left and right panels in B 
are representative higher magnification images taken as shown by the white boxed area in 
A. CA: Cornus Ammonis; DG: dentate gyrus. Scale bars, 100 µm. 
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 Figure 3.4 Decreased nestin total protein levels in male pallid hippocampi at 
postnatal day (P)1. (A) Representative immunoblots of hippocampal extracts from both 
males and females wild-type (WT) and pallid mice at P1. β-actin was used as a loading 
control. (B) Each band was analyzed by densitometry corrected for background, 
normalized to β-actin levels. Data are shown as the mean ± S.E.M. of the ratio of each 
pallid and its respective WT, n = 5 animals per genotype per gender. Statistical 
significance was assessed using a one-sample t-test. **p<0.01, ns, not significant. 
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 Figure 3.5 Reelin protein expression levels are not altered by the lack of BLOC-1 at 
postnatal day (P)1. (A) Representative immunoblots of hippocampal extracts showing 
no differences in the total protein of the three main forms of reelin, (full-length, 400 kDa, 
plus two cleaved fragments, 300 kDa, and 180 kDa) in males and females wild-type 
(WT) and pallid mice. β-actin was used as a loading control. (B) Each band was analyzed 
by densitometry, corrected for the background, normalized to β-actin levels. Data are 
shown as the mean ± S.E.M. of the ratio of each pallid and its respective WT, n = 5 
animals per genotype per gender. Statistical significance was assessed using a one-sample 
t-test. ns, not significant. 
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Figure 3.6 The expression levels of the immature neuronal marker, doublecortin, are 
marginally altered in postnatal day (P)1 male pallid CA1, but not in females. (A) Left 
panels, in WT CA1, doublecortin-positive neuronal cells appeared well organized throughout the 
entire CA1 cell layer. Right panels, in pallid hippocampi, the expression level of doublecortin 
appeared to be slightly decreased in the CA1 cell layer (arrows). (B) This phenotype is less 
apparent in pallid females. Sections (40 µm) from male and female mice in A and B were stained 
using a rabbit polyclonal anti-doublecortin antibody. White boxes indicate regions shown at 
higher magnification. Left and right panels in B are representative higher magnification images 
taken as shown by the white boxed area in A. CA: Cornus Ammonis; DG: dentate gyrus. Scale 
bars, 100 µm. 
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 Figure 3.7 The expression pattern of the immature neuronal marker, α-internexin, is 
altered in postnatal day (P)1 male pallid CA1, but not in females. (A) Left panels, in 
WT CA1, immature neurons immunopositive for α-internexin appeared well organized 
throughout the entire CA1 cell layer. Right panels, in pallid hippocampi, the distribution 
pattern of α-internexin-positive neurons, appear malpositioned, especially around the 
subiculum (arrows). (B) Pallid females displayed well distributed α-internexin-positive 
neurons as seen in the WT females and males. Sections (40 µm) from male and female 
mice in A and B were stained using a rabbit polyclonal anti-α-internexin antibody. White 
boxes indicate regions shown at higher magnification. Left and right panels in B are 
representative higher magnification images taken as shown by the white boxed area in A. 
CA: Cornus Ammonis; DG: dentate gyrus. Scale bars, 100 µm. 
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 Figure 3.8 The expression pattern of the immature neuronal marker, βIII-tubulin, is 
altered in postnatal day (P)1 male pallid CA1, but not in females. (A) Left panels, in 
WT displayed well distributed βIII-tubulin-positive neurons throughout CA1. Right 
panels, in pallid hippocampi, the expression pattern of βIII-tubulin-positive neurons was 
disorganized (arrows). (B) Pallid females were not impacted by lack of BLOC-1 and their 
CA1 was not different from WT. Sections (40 µm) from male and female mice in A and B 
were stained using a rabbit polyclonal anti-βIII-tubulin antibody. White boxes indicate 
regions shown at higher magnification. Left and right panels in B are representative 
higher magnification images taken as shown by the white boxed area in A. CA: Cornus 
Ammonis; DG: dentate gyrus. Scale bars, 100 µm. 
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 Figure 3.9 The total protein levels of immature neuronal marker doublecortin are 
not impacted by lack of BLOC-1. (A) Representative immunoblots of hippocampal 
extracts from both males and females wild-type (WT) and pallid mice at P1. β-actin was 
used as a loading control. (B) Each band was analyzed by densitometry corrected for 
background, normalized to β-actin levels. Data are shown as the mean ± S.E.M. of the 
ratio of each pallid and its respective WT, n = 5 animals per genotype per gender. 
Statistical significance was assessed using a one-sample t-test. ns, not significant. 
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 Figure 3.10 The total protein levels of immature neuronal marker α-internexin are 
not affected by lack of BLOC-1. (A) Representative immunoblots of hippocampal 
extracts from both males and females wild-type (WT) and pallid mice at P1. β-actin was 
used as a loading control. (B) Each band was analyzed by densitometry corrected for 
background, normalized to β-actin levels. Data are shown as the mean ± S.E.M. of the 
ratio of each pallid and its respective WT, n = 5 animals per genotype per gender. 
Statistical significance was assessed using a one-sample t-test. ns, not significant. 
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 Figure 3.11 Lack of BLOC-1 does not affect the total protein elevs of immture 
neuronal marker βIII-tubulin. (A) Representative immunoblots of hippocampal 
extracts from both males and females wild-type (WT) and pallid mice at P1. β-actin was 
used as a loading control. (B) Each band was analyzed by densitometry corrected for 
background, normalized to β-actin levels. Data are shown as the mean ± S.E.M. of the 
ratio of each pallid and its respective WT, n = 5 animals per genotype per gender. 
Statistical significance was assessed using a one-sample t-test. ns, not significant. 
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CHAPTER 4 
Dendritic arborization abnormalities in hippocampal neurons 
deficient in BLOC-1  
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ABSTRACT 
Previous in vitro studies had shown that BLOC-1-deficient hippocampal neurons have deficient 
neurite elongation. To examine whether such abnormality is present in vivo as well, I have 
analyzed the cytoarchitecture of hippocampal neurons in wild-type and BLOC-1-deficient mice, 
at postnatal day 60 using the Golgi method. Neurons in two hippocampal areas known to 
involved in cognitive and behavioral deficits, the Dentate Gyrus and Cornus Ammonis (CA)1, 
were examined. Morphological analyses revealed a significant decrease in the number of 
dendrites in the granule cells of the Dentate Gyrus, but no changes in the length. Conversely, I 
did not find any deficiencies in CA1 pyramidal neurons. These results reinforce the likelihood of 
a prosed function for BLOC-1 in brain development and its involvement in process elongation. 
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INTRODUCTION 
Published studies suggest a role for BLOC-1 in brain development, and more particularly, 
in membrane trafficking and neurite elongation. Our lab previously reported that primary 
hippocampal neurons from newborn pallid mice, deficient in BLOC-1, display decreased number 
of neurites when grown for three days, and, sum of the lengths of all neurites per cell [1]. In 
agreement, similar  findings were shown in neurons cultured from the sandy mice, another model 
of BLOC-1 deficiency [2]. Additionally, siRNA-mediated knockdown of dysbindin in a mouse 
neuroblastoma cell lines caused a decrease in the neurite length in cultured neuroblastoma cells 
[2]. Lastly, in cultured rat hippocampal neurons, RNA interference-mediated knockdown of 
endogenous dysbindin resulted in abnormal dendritic spine formation [3].   
Altogether these findings point to a role for BLOC-1 in neurite development, but they 
were all performed in vitro, where the growth conditions do not completely recapitulate the brain 
environment. Thus, I have analyzed the cytoarchitecture of hippocampal neurons from postnatal 
day (P)60 wild-type and pallid brains using the Golgi method followed by Sholl analysis to 
determine if lack of BLOC-1 affect the dendritic arborization of hippocampal neurons in the 
Dentate Gyrus, and Cornus Ammonis (CA)1. Furthermore, it was important to determine 
whether the alternations seen early in postnatal development but absent in young adult, had 
caused any abnormality in young brains. 
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EXPERIMENTAL PROCEDURES 
Animals 
Mouse strains were used and maintained as described in Chapter 2. 
Golgi 
 Whole brains were rapidly dissected from P60 wild-type (WT) and pallid mice (n = 5 
animals per genotype) and then processed following the FD Rapid GolgiStain Kit 
manufacturer’s instructions (FD NeuroTechnologies). Briefly, the brains were placed into 
the Golgi-Cox solution (provided in the kit) for 2 weeks at room temperature in the dark. 
Golgi stained brains were then sectioned (100 µm) coronally on a vibratome (Electron 
Microscopy Sciences). Sections were collected in phosphate-buffer saline (PBS) and 
mounted on gelatin-coated glass microscope slides and developed with the silver-mercury 
solutions provided in the kit. Cover-slips were mounted using Permount mounting media.  
Image collection and analysis 
Pyramidal neurons from the CA1 and granule cells from the Dentate Gyrus of the 
hippocampus were selected based on their dark impregnation, projected, and traced. An 
upright microscope (Leica) equipped with a camera lucida was used. A minimum of 15 
neurons were selected from each brain region per animal, and 5 animals per genotype 
were analyzed. Two quantitative analyses were used to examine the complexity of the 
dendritic arbor. 1) The Sholl analysis: a template of equally spaced concentric circles (15 
µm) was overimposed to each traced neuron paying extra attention to place the cell body 
!  63
in the center of the smallest circle (Fig. 4.1A) [4]. The number of dendrites that crossed 
each concentric circle was counted and the number of dendritic intersections per circle 
was plotted against the distance of the circle. Additionally, the primary, secondary and 
tertiary dendrites of each neuron were counted and traced using the Axiovision software 
(Zeiss, Verison 4.8) (Fig. 4.1B). Both analyses were performed by two independent 
investigators masked to the genotype of the animals. Statistical significance was 
determined by two-way ANOVA (Analysis of Variance) followed by Bonferroni’s 
multiple comparison test using the GraphPad Prism 5.0b (GraphPad Software).  
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RESULTS 
Defect in dendritic arborization in granule cells deficient in BLOC-1 
 I analyzed the dendritic arborization of hippocampal neurons in the Dentate Gyrus (Fig. 
4.2 A,B) and CA1 (Fig. 4.2 C,D) of P60 WT and pallid mice. Sholl analysis revealed a 15-24% 
decrease in the number of processes crossing the 30-60 µm away from the cell body, in pallid 
granule neurons as compared to WT (Fig. 4.3A). On the other hand, no differences were found in 
the numbers, of apical and basal dendrites of CA1 between pallid and WT pyramidal neurons 
(Fig 4.3 B,C). Next, the length and number of primary, secondary and tertiary dendrites were 
examined to further characterize the dendritic arbors. Again, pallid granule cells displayed a 
significantly, decreased number of all orders of dendrites (Fig. 4.4A), and a significant decrease 
in the branch points of only the the tertiary dendrites (Fig. 4.4B) compared to those of the WT. 
No abnormalities were found in the length of the dendrites in the pallid granules or pyramidal 
cells (Fig. 4.4C, Fig. 4.5A-D). 
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DISCUSSION 
 Here I examined the dendritic arborization of BLOC-1-deficient hippocampal neurons 
was examined in vivo. The results showed that, in the Dentate Gyrus, the BLOC-1-deficient 
granule neurons had fewer dendrites, particularly tertiary dendrites, than the WT granule 
neurons. Additionally, the BLOC-1-deficient granule neurons had fewer branch points in the 
tertiary dendrites than the WT granule neurons. These results suggest that the BLOC-1-deficient 
granule neurons have a decrease in the complexity of the dendritic arborization, possibly leading 
to cognitive and behavioral deficiencies [5].  
 A few possible mechanisms by which BLOC-1 regulates neurite outgrowth can be 
proposed. For instance, our lab reported that BLOC-1 interacts with the SNARE proteins, 
SNAP-25, and syntaxin 13 [1], known to be involved in delivery of membranes from an 
intracellular compartment to the growth cones [7-10]. Another important player may be VAMP7, 
for which a role of neurite outgrowth in cultured cells was proposed by Galli and colleagues 
[11-13]. Marcs and colleagues [14,15] showed that VAMP7 is a BLOC-1-dependent cargo 
protein. Furthermore, VAMP7 interacts with SNAP-47, another component of the BLOC-1 
interactome [1,16]. Thus, it is possible that through the interaction with or regulation of these 
proteins, BLOC-1 may affect neurite development. Altogether these findings, including mine, 
suggest that BLOC-1 plays a critical role(s) in brain development, one of them being regulation 
of process outgrowth in neural cells (not limited to neurons). Most importantly, its lack causes 
delays in central nervous system development and disturbs proper brain wiring leading to 
cognitive and behavioral deficits. 
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 Figure 4.1 Image analyses of Golgi-stained hippocampal neurons. (A) For the Sholl 
analysis, a template of concentric circles was placed on the trace image of hippocampal 
neurons. The smallest circle was 30 µm from the center and the other concentric circles 
were spaced 15 µm apart from the preceding circle. The number of dendrites that cross 
each concentric circle was determined (B) The primary, secondary, and tertiary dendrites 
were traced. The red, green, and blue lines are representative traces of primary, 
secondary, and tertiary dendrites respectively. The number of dendrites and the length of 
each dendrite were measured. 
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 Figure 4.5 Analysis of the primary, secondary and tertiary dendrites show no 
differences in pyramidal neurons of the wild-type (WT) and pallid mice. Primary, 
secondary and tertiary dendrites of each pyramidal neuron were analyzed to measure the 
number of branches and the length of each branch. (A,B) Values represent means ± 
S.E.M of the number of dendrites from the apical (A) and basal (B) dendrites (C,D) 
Values represent means ± S.E.M of the length of each dendrite from the apical (C) and 
basal (D) dendrites. A minimum of 15 neurons per animal per genotype in CA1 areas 
were selected and a total of 5 animals per genotype were examined. Statistical 
significance was determined using a two-way ANOVA (analysis of variance) followed by 
Bonferroni’s multiple comparison tests. ns, not significant. 
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CHAPTER 5 
Examination of the assembly of BLOC-1 with alternative subunits  
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ABSTRCT 
The BLOC-1 subunits were first identified in liver and in skin fibroblasts, but more 
recently there has been a growing interest in the role of BLOC-1 in brain. Two of the 
BLOC-1 subunits, dysbindin and pallidin, have alternatively spliced variants that are 
expressed in brain, and some of them seem to be human-specific. Some groups have 
suggested that one ore more of these alternatively spliced variants may not assemble into 
BLOC-1 and instead function independently of the complex. In addition to these subunit 
variants generated by alternative splicing, the genomes of humans and other mammals - 
but not those of other vertebrates - contain an uncharacterized gene encoding a paralog of 
the cappuccino subunit. To test whether or not these alternative forms of BLOC-1 
subunits can assemble into a complex with the other subunits, I utilized a polycistronic 
plasmid that expresses all eight subunits of BLOC-1 in bacteria. Results show that 
dysbindin isoform B is able to assemble into a stable complex. In contrast, dysbindin 
isoform C, a second isoform of pallidin, and the cappuccino paralog are unable to. 
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INTRODUCTION 
 Some of the BLOC-1 subunits have alternative isoforms or paralogs. Dysbindin is 
described to have multiple isoforms, but only three of them, isoforms A, B, and C, have 
been reported to be expressed in human brains [1]. Dysbindin isoform A is the full-length 
form of dysbindin and is encoded by a transcript with 10 exons (Fig. 5.1). Dysbindin 
isoform B is encoded by a transcript that includes exons 1-9, followed by an alternative 
sequence (Fig. 5.1). Dysbindin isoform C is encoded by a transcript that has a different 
start codon, within exon 5, and so is truncated in the N-terminal (Fig. 5.1). Because of the 
initial study linking DTNBP1 and schizophrenia, the protein expression of the dysbindin 
isoforms was examined in postmortem brains of normal and schizophrenic individuals. It 
was reported that protein levels of dysbindin isoforms were decreased in specific brain 
areas of individuals with schizophrenia in an isoform-dependent manner [1]. As a result, 
it was suggested that these alternative isoforms may have unique functions in the brain.  
 A few studies tried to further characterize dysbindin isoform B and C by 
examining whether these alternative isoforms were part of a complex like BLOC-1, but 
led to conflicting results. One study reported that isoforms A, B, and C were expressed in 
mice, and that isoforms B, and C did not assemble into a complex like BLOC-1 [2]. 
However, another group reported that only isoforms A, and C were expressed in mice, 
and that isoform C did not assemble into a complex like BLOC-1 [3]. To make matters 
more confusing, the first study identified by immunoblot analysis, a 35-kDa band as 
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isoform B and a 32-kDa band as isoform C, while the second study identified a 35-kDa 
band as isoform C [2,3].   
 Pallidin is another subunit of BLOC-1 that is reported to have an alternatively 
spliced isoform. Pallidin isoform 1 is the full-length form and has 172 residues, while 
pallidin isoform 2 has 101 residues (Fig. 5.2). The transcript encoding pallidin isoform 2 
shares only exon 2 with the transcript encoding pallidin isoform 1. In a previous study, it 
was reported only pallidin isoform 2 was expressed in human brain, suggesting that in the 
human brain BLOC-1 would have to assemble with pallidin isoform 2 [4].  
 Lastly, it was reported that the BCAS4 gene encodes a paralog of cappuccino [5]. 
In a study that investigated cytosolic protein interactions involving dysbindin, it was 
reported that the BCAS4 protein was one of several binding partner of dysbindin [6]. In a 
second unbiased proteomic study, a BCAS4 fusion protein was one of 2,594 baits used to 
identify protein interaction networks. It was found that the BCAS4 protein associated 
with all the BLOC-1 subunits except cappuccino, suggesting that BCAS4 might be able 
to replace cappuccino as a subunit of BLOC-1 [7]. 
 Previously, a polycistronic plasmid was designed with the open reading frame 
(ORF) encoding all eight subunits of BLOC-1, and two of the subunits, dysbindin and 
pallidin, had affinity tags, GST and HIS6 respectively (Fig. 5.3) [8]. In that study, it was 
shown that when recombinant BLOC-1 was disrupted by removing parts of some 
subunits, two subcomplexes formed: subcomplex-1, which includes pallidin, cappuccino, 
and BLOS1, and subcomplex-2, which includes dysbindin, BLOS2, and snapin [8].  
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 To answer the question of whether these alternatively spliced isoforms or paralog 
could form a stable complex with the other BLOC-1 subunits, I have obtained the 
polycistronic plasmid that expresses recombinant BLOC-1, and engineered variations of 
this plasmid where the ORFs of full-length subunits were removed and replaced with 
those of the alternative subunits. Additionally, the yeast two-hybrid (Y2H) system was 
used to examine binary interactions of the alternative isoforms. Lastly size-exclusion 
chromatography analysis was done to determine the size of complexes containing 
alternative isoforms of dysbindin. 
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EXPERIMENTAL PROCEDURES 
DNA constructs 
A modified polycistronic pST39 vector that had the human cDNA sequences of all BLOC-1 
subunits, pallidin, dysbindin, BLOS2, cappuccino, snapin, BLOS3, BLOS1 and muted was given 
as a gift from the laboratories of Drs. James Hurley and Juan Bonifacino [8]. In this polycistronic 
pST39 vector each, ORF contained the Shine-Dalgarno translational start signal. A histidine 
(HIS6)-tag was attached to the N-terminus of pallidin and a glutathione S-transferase (GST)-tag 
was attached to the C-terminus of dysbindin. Two tobacco etch virus (TEV) protease cleavage 
sites were placed in the construct, one between pallidin and HIS6-tag and the other located within 
dysbindin (between residues 259 and 260).  
To replace the full-length ORF of dysbindin, pallidin, and cappuccino with their alternative 
isoforms or paralogs, the cDNA sequence was designed and ordered for synthesis in the pCR2.1 
plasmid by Eurofins. The ORFs of the full-length subunits were removed with appropriate 
restriction enzymes and replaced with those of the alternative forms in-frame. 
Y2H plasmids 
The ORFs of dysbindin isoform B, dysbindin isoform C, and pallidin isoform 2, were designed 
and ordered for synthesis by Eurofin. The ORFs were cloned into the EcoRI/SalI sites of pGBT9 
or pGAD424 vectors (Clonetech) to generate the expression constructs used in the Y2H analysis. 
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The Y2H construct expressing the BCAS4 protein was generated by Marta Starcevic [10]. All 
other Y2H constructs are described in [9].  
Production of recombinant proteins 
For production of the recombinant BLOC-1, E.coli strain BL21 Star (DE3) (Invitrogen by 
Thermo Fisher Scientific) was transformed with the appropriate plasmid and cultured in 1.2 liters 
of 2xYT media [18 g/l tryptone, 11 g/l yeast extract, 5.6 g/l NaCl] in two 2-liter Erlenmeyer 
flasks. At an optical density at 600 nm (OD 600) of 0.6, protein expression was induced with 0.2 
mM isopropyl-beta-D-thiogalactopyranoside (IPTG) for 14-16 hours at 20°C. Pelleted cells, 
obtained by centrifugation at 6,000 x g for 15 mins, were homogenized in 30 ml of buffer A [20 
mM Tris (pH 8.0) and 500 nM NaCl] supplemented with 30 µl of protease inhibitor mixture 
(Sigma, catalog number P8849), and sonicated using a Branson Sonifier 450 (output #5, 50% 
duty cycle, 30 seconds on, 15 seconds off, 6 times). Appropriate amounts of triton X-100 were 
added to bring its concentration of 1%, and the homogenate was incubated in 4°C for 30 min. 
Lysates were cleared by centrifugation at 6,000 x g for 15 mins.  
For the GST-affinity purification, the cleared lysates were incubated for 1 h at 4°C with 300 µL 
of glutathione-Sepharose 4 Fast-Flow beads (GE Healthcare Life Sciences). The beads were 
washed once with 30 ml of buffer A with 1% (w/v) triton X-100 and three times with 30 ml of 
buffer A. The recombinant proteins were eluted 4 times with 700 µL of 20 mM  glutathione in 
0.1M Tris-HCl, pH 8.0. 
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For the HIS6-affinity purification, the cleared lysates were incubated for 1 h at 4°C with 300 µL 
of Talon® Superflow resin (Clonetech). The beads were washed once with 30 ml of buffer A 
with 1% (w/v) triton X-100, once with 30 mL of buffer A alone, once with 30 mL of buffer A 
with 20 mM Imidazole, and three times with 30 ml of buffer A. The recombinant proteins were 
eluted 4 times with 700 µL of 1 M Imidazole in T1 buffer [300mM NaCl, and 50 mM Na2PO4, 
pH 7.0]. 
For the sequential affinity purification (tandem purification), E.coli strain with the appropriate 
plasmid was cultured in 3.6 liters of 2xYT media in six 2 liter erlenmeyer flasks and the GST-
purification steps were followed as described above. The eluted proteins were pooled together, to 
a total volume of 8.4 mL. 10 mL of buffer A with 0.1% (w/v) BSA, 1% (w/v) triton X-100, 
supplemented with protease inhibitors, and 300 µL of Talon® Superflow resin, supplemented 
with protease inhibiter were added to the eluted GST-purified samples and incubated for 1 hr at 
4°C. The beads were washed once with 30 ml of buffer A with 1% (w/v) triton X-100, once with 
30 mL of buffer A, once with 30 mL of buffer A with 20 mM Imidazole,  and three times with 30 
ml of buffer A. The recombinant proteins were eluted 4 times with 700 µL of 1 M Imidazole in 
T1 buffer. 
Antibodies 
The monoclonal antibody to pallidin clone (2G5) and the antiserum to anti-muted were described 
previously in [11]. Polyclonal antibodies against dysbindin, snapin, BLOS3, BLOS2, and 
BLOS1 were described in [9]. The polyclonal antibody to GST is described in [12]. The 
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monoclonal antibody to cappuccino (clone 6C3)  was purchased from Novus Biologicals. The 
monoclonal antibody to HIS6 (catalog number 34660) was purchased from Qiagen. Primary 
antibodies were used at the following concentrations: rabbit anti-BLOS1 = 1:1,000; rabbit anti-
BLOS2 = 1:1,000; rabbit anti-BLOS3 = 1,000; mouse anti-cappuccino = 1:500; rabbit anti-
dysbindin = 1:10,000; rabbit anti-GST = 1:5,000; mouse anti-HIS6 = 1:1,000; rabbit anti-muted = 
1:1,000; mouse anti-pallidin = 1:1,000; rabbit anti-Snapin = 1:1,000. Rabbit and mouse HRP 
horseradish peroxidase-conjugated secondary antibodies (GE Healthcare Life) were used at a 
concentration of 1:3,000. 
Gel electrophoresis and Coomassie-blue staining 
Induced bacterial pellets and purified proteins were heated to 65°C for 5 mins and 95°C for 5 
mins following the addition of an equal volume of 2X sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) sample buffer [50 mM Tris-HCl, pH 6.8, 15.6 g/l dithiothreitol, 
0.1 g/l bromophenol blue, 4% (w/v) SDS, 12% (w/v) glycerol]. Proteins were resolved by SDS-
PAGE on 4-20% Tris-Glycine gels (Invitrogen by Thermo Fisher Scientific). Analysis for the 
Coomassie-blue staining was carried out as described previously in [13]. Briefly, gels were 
incubated in Coomassie-blue staining solution [0.1% (w/v) Coomassie brilliant blue R-250, in 
30% (v/v) methanol, 10% (v/v) acetic acid in distilled water] with gentle agitation for 1 hour. 
Coomassie-blue staining solution was removed and the gel was briefly rinsed with distilled 
water. Stained gels were then incubated in ~100 mL of destaining solution [30% (v/v) methanol, 
10% (v/v) acetic acid in distilled water] until the solution became as dark as the gel matrix. The 
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destaining solution was then discarded, and gels were incubated in new destaining solution until 
the gel had a clear background. Gels were imaged on the ChemiDoc Imaging System (Biorad). 
Immunoblotting analysis 
Proteins were resolved by SDS-PAGE as described above and were transferred onto 
polyvinylidene difluoride membranes (BioRad) at 100 V for 60 mins at 4°C in transfer buffer [25 
mM Tris-base, 192mM glycine, 20% (v/v) methanol]. The membranes were incubated in 
blocking buffer [5% (w/v) non-fat dry milk and 0.2% (w/v) Tween® 20 in phosphate-buffered 
saline (PBS)] overnight at 4°C. Membranes were then incubated with primary antibody diluted 
in blocking buffer for 1 hour, washed 3 times for 10 min in PBS, incubated for 30 mins at room 
temperature with appropriate secondary antibody diluted in blocking buffer, and again washed 3 
times for 10 min in PBS. Detection was performed using the ECL PrimeTM Western Blotting 
Detection Reagent (GE Healthcare Life Sciences) according to the manufacturer’s instructions. 
For quantitative analysis of protein expression levels, enhanced chemiluminescence signals were 
captured on the ChemiDoc Imaging System (Biorad) and digitally integrated using the National 
Institutes of Health Image Software (Image J, http://rsb.info.nih.gov/ij/). For the comparison of 
relative protein levels, the mean pixel intensity was measured for each band using the same area 
for bands on the same membrane. The pixel intensity of the background was subtracted from the 
pixel intensity of each band on the same membrane. Background-corrected values were then 
divided by the background-corrected values of the affinity tags (GST or HIS6) used for 
purification. Statistical significance was determined by Student’s T-test using the GraphPad 
Prism 5.0b (GraphPad Software). Because multiple tests were done, the threshold for 
!  84
significance was made more stringent by dividing the α = 0.05 by number of tests. This new α 
was used as the threshold for significance.   
Silver staining 
Analysis with silver staining was carried out as described previously in [13]. Proteins were 
resolved by SDS-PAGE as described above. In each step, gels were incubated with gentle 
agitation. Gels were incubated in 50% (v/v) ethanol in water for 20 mins. This step was repeated 
2 more times for a total of three pretreatment steps. Gels were then incubated in deionized water 
for 5 mins. Deionized water was discarded and gels were incubated in 100 mL of thiosulfate 
solution [0.02% (w/v) Na2SO5.5H2O in water] for exactly 1 min, washed with deionized water 
three times for 20 sec each and incubated in silver nitration solution [0.2%(w/v) AgNO3 with 75 
µL of 37% (w/v) formaldehyde per 100 mL of water] for 20 mins. The container was covered 
with aluminum foil to protect from light exposure. Gels were then washed with deionized water, 
three times for 20 sec each, and incubated in developer solution [6% (w/v) Na2CO3, 0.0004% (w/
v) Na2SO5.5H2O, 50 µL of 37% formaldehyde per 100 mL of water] for < 10 mins until the 
protein bands of interest became visible. Gels were then washed with deionized water three times 
for 30 sec each, incubated in a solution [50% (v/v) methanol, 12% (v/v) acetic acid in deionized 
water] for 10 mins, and then incubated in 50% (v/v) methanol in deionized water. Gels were then 
removed from the 50% (v/v) methanol solution, placed on the platform of the ChemiDoc 
Imaging System (Biorad) and imaged. 
Size-exclusion chromatography analysis 
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After purification of the recombinant BLOC-1 with the glutathione-Sepharose 4 Fast-Flow 
beads, 4 µL of TEV protease (Invitrogen) were added to the purified samples and the purified 
samples were dialyzed against dialysis buffer [50 mM Tris (pH 7.4), 300 mM NaCl and 5 mM β-
mercaptoethanol]. The GST tag was removed from the digested sample by incubating with 100 
µL of glutathione-Sepharose 4 Fast-Flow beads. For size-exclusion chromatography, 500 µL of 
purified protein sample were loaded onto a Superose 6 column connected to a Fast Protein 
Liquid Chromatography system (Amersham Biosciences). Proteins were eluted at 4°C in FPLC 
buffer [0.4 M NaCl, 0.05 M Tris (pH 7.4), 1 mM EDTA, 1 mM tris(2-carboxyethyl) phosphine, 
and 5% (v/v) glycerol] at a flow rate of 0.4 ml/min, collected into 0.4 ml fractions, and analyzed 
by silver staining and immunoblotting. Calibration of the column was performed using blue 
dextran (Sigma), to determine the exclusion volume, and the following standard proteins (Stokes 
radii in parentheses): bovine thyroglobulin (85Å, Sigma), horse spleen apoferritin (61Å, Sigma), 
bovine serum albumin (36Å, Fisher Scientific), carbonic anhydrase (24Å, Sigma), and horse 
heart cytochrome c (17Å, Sigma).  
Y2H analysis 
Expression constructs were co-transformed into Saccharomyces cerevisiae strain AH109 using 
the lithium acetate method [14], and double transformants were selected in SD minimal medium 
[0.7% (w/v) yeast nitrogen base without amino acids (Sigma) and 2 % (w/v) glucose, pH 5.5] 
supplemented with the appropriate nutritional requirements (adenine and histidine) except 
leucine and tryptophan. Cell suspensions of each co-transformant  (OD 600 = 0.4) were spotted 
onto control plates containing adenine and histidine as well as on and selective plates lacking 
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histidine and lacking or containing 5 mM 3-amino-1,2,4-triazole (3-AT). Plates were incubated 
for 3 days at 30°C before imaging on the ChemiDoc Imaging System (Biorad). 
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RESULTS 
Expression and purification of recombinant BLOC-1  
 After receiving the polycistronic plasmid that expressed recombinant BLOC1, I wanted 
to verify that I was able to express and purify all eight subunits of BLOC-1. To this end, E. Coli 
was transformed with this polycistronic plasmid, and immunoblot analysis was done using 
antibodies to the eight subunits of BLOC-1 (Fig. 5.4). From here on, the recombinant BLOC-1 
expressed from this plasmid will be referred to as BLOC-1(WT). To determine if a complex was 
forming, I performed tandem purification of the BLOC-1(WT) using both GST- and HIS6- tags. 
The tandem purification was optimized and is described in further detail under Experimental 
Procedures. Coomassie-blue staining of the tandem purified BLOC-1(WT) showed eight bands, 
and immunoblot analysis was used to identify the eight bands as the BLOC-1 subunits (Fig. 5.5).  
Dysbindin isoform B, but not isoform C, was able to replace dysbindin isoform A to form a 
stable complex. 
 Next, I designed new constructs that replaced the ORF encoding the full-length dysbindin 
with those encoding the alternative forms of dysbindin, isoform B or C, in-frame. Recombinant 
BLOC-1 with dysbindin isoform B will be referred to as BLOC-1(IsoB) and recombinant 
BLOC-1 with dysbindin isoform C will be referred to as BLOC-1(IsoC). Because the TEV site 
had been originally designed within the dysbindin subunit in BLOC-1(WT), I made a new 
construct where the TEV site was moved to the sequence between dysbindin and the GST tag. 
The recombinant BLOC-1 expressed from this new construct will be referred to as BLOC-1 
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(IsoA). All eight subunits of BLOC-1 were co-expressed from these three polycistronic plasmids 
in E. Coli (Fig. 5.6). GST-, HIS6- and tandem purification of BLOC-1(IsoB) yielded comparable 
amounts of each BLOC-1 subunit (Fig. 5.6) and quantification of the signal intensity from the 
immunoblots to the BLOC-1 subunits showed equal amounts of almost every subunits after GST- 
(Fig 5.7) or HIS6-purification (Fig. 5.8). Although not statistically significant, it appeared that 
there was an increase in the protein levels of the cappuccino subunits after GST purification of 
BLOC-1(IsoB) (Fig. 5.7).  However, after the affinity tags were cleaved by TEV protease, the 
sample dialyzed, and the GST tag removed by incubating again with glutathione beads, the levels 
of cappuccino in BLOC-1(IsoB) were comparable to those in BLOC-1(IsoA), suggesting that 
there may have been a weak or transient interaction between BLOC-1(IsoB) and an additional 
molecule of cappuccino (Fig. 5.9). After GST- and HIS6-purification of BLOC-1(IsoC), all 
subunits of BLOC-1 were detected, but after tandem purification of BLOC-1(IsoC), the 
cappuccino subunit was absent (Fig. 5.6). Quantification of the signal intensity from the 
immunoblots to the BLOC-1 subunits showed signficant decreases in some of the BLOC-1 
subunits in both GST- (Fig. 5.10) and others in the HIS6-purifications (Fig. 5.11) of 
BLOC-1(IsoC), indicating that BLOC-1(IsoC) does not form a stable complex. 
 To examine direct interactions of dysbindin isoforms B and C with subunits known to 
interact with dysbindin isoform A, the Y2H system was used. Dysbindin isoforms were fused to 
the Gal4 DNA-activation domain, and dysbindin isoforms B and C were found to interact with 
pallidin, snapin and muted, the same subunits that dysbindin isoform A interacted with (Fig. 
5.12). 
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Because it seemed that BLOC-1(IsoB) was forming a stable complex and that BLOC-1(IsoC) 
might be forming a sub-complex, size-exclusion chromatography analysis was performed to 
determine the size of BLOC-1(IsoB) and BLOC-1(IsoC). In an initial experiment with the GST-
purified BLOC-1(IsoA), a clear species could not be resolved, but instead BLOC-1 subunits, 
particularly dysbindin-GST, were detected in a number of fractions, suggesting that the GST tag 
was dimerizing. To resolve this issue, the GST tag was removed by digestion with TEV protease. 
Upon digestion, there was a shift in apparent molecular weight for all three dysbindin isoforms 
(Fig. 5.13, arrows and arrowheads). The digested BLOC-1(IsoA), BLOC-1(IsoB) and 
BLOC-1(IsoC) were analyzed by size-exclusion chromatography, and the species in the fractions 
were analyzed by SDS-PAGE followed by silver staining and immunoblot with antibodies to 
selected BLOC-1 subunits. For BLOC-1(IsoA), the bulk of BLOC-1 subunits eluted from the 
column in fractions corresponding to a Stokes radius of ~98 Å (Fig. 5.12), similar to the reported 
Stokes radius (~94 Å) of BLOC-1 in liver [9]. Several of the BLOC-1 subunits eluted in later 
fractions (Fig. 5.14), indicating that not every molecule of BLOC-1(IsoA) subunits assembled 
into a complex. For BLOC-1(IsoB), the bulk of BLOC-1 subunits eluted from the column in 
fractions corresponding to a Stokes radius of ~89 Å (Fig. 5.15). Like BLOC-1(IsoA), several of 
the BLOC-1 subunits of BLOC-1(IsoB) also eluted in later fractions (Fig. 5.15). Lastly for 
BLOC-1(IsoC), there was no clear fraction that included all the BLOC-1 subunits (Fig. 5.16). 
Instead, the different subunits were eluting in different fractions. 
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Pallidin isoform 2 could not replace pallidin isoform 1 to form a stable complex with the 
other BLOC-1 subunits. 
 To determine if the alternative isoform of pallidin could replace the full-length pallidin 
and form a complex with the other BLOC-1 subunits, I designed a new construct where the ORF 
encoding pallidin isoform 1 was replaced with that of pallidin isoform 2. Recombinant BLOC-1 
with pallidin isoform 2 will be referred to as BLOC-1(Iso2). All subunits of BLOC-1 were co-
expressed from the polycistronic plasmid with the ORF encoding pallidin isoform 2, but the 
protein levels of cappuccino appeared to be less than the cappuccino levels expressed from the 
WT polycistronic plasmid, already indicating that the steady-state protein levels were disrupted 
in BLOC-1(Iso2) (Fig. 5.17). After GST-purification of BLOC-1(Iso2), subunits of 
subcomplex-2 were present, but the protein levels of the other subunits appeared to be decreased 
or absent (Fig. 5.17). After HIS6-purification of BLOC-1(Iso2), subunits of subcomplex-2 were 
detected along with pallidin isoform 2, muted and BLOS3 (Fig. 5.17). After tandem purification, 
none of the BLOC-1 subunits were detected, except for a small amount of dysbindin (Fig. 5.17). 
These results suggested that pallidin isoform 2 may have a weak interaction with subcomplex-2 
but not be able to form a stable complex. Quantification of the signal intensity from the 
immunoblots to the BLOC-1 subunits after GST purification (Fig. 5.18) and HIS6-purifications 
(Fig. 5.19) confirmed these observations. Analysis of the binary interactions between pallidin 
isoform 2 with subunits known to interact with pallidin isoform 1 showed that the former does 
not interact with any of the BLOC-1 subunits that the latter interacted with (Fig. 5.20), which 
further supported that BLOC-1(Iso2) does not form a stable complex. 
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The BCAS4 protein could not replace cappuccino to form a stable complex with the other 
BLOC-1 subunits. 
 To determine if the paralog of cappuccino, the BCAS4 protein, could replace the 
cappuccino subunit, the ORF encoding cappuccino was replaced with that encoding the BCAS4 
protein. As a negative control, the ORF encoding cappuccino was removed and not replaced with 
anything. Recombinant BLOC-1 with the BCAS4 protein will be referred to as 
BLOC-1(BCAS4) and the recombinant BLOC-1 without cappuccino will be referred to as 
BLOC-1(-CNO). All seven subunits of BLOC-1 and the BCAS4 protein were co-expressed from 
the polycistronic plasmid in E. Coli (Fig. 5.21). However after GST-purification of 
BLOC-1(BCAS4), little to no amounts of BLOC-1 subunits were detected and in the tandem 
purification of BLOC-1(BCAS4), none of the BLOC-1 subunits were purified (Fig 5.21). 
Analysis of the binary interaction between BCAS4 and subunits known to interact with 
cappuccino showed that BCAS protein interacts with pallidin, but not with snapin and BLOS1 
(Fig. 5.22) 
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DISCUSSION 
 I have used a heterologous expression system to determine if alternative isoforms of 
BLOC-1 can form a stable complex with the other BLOC-1 subunits. Of the alternative isoforms 
examined, only dysbindin isoform B appeared to form a complex with the other BLOC-1 
subunits. After GST-, HIS6-, and tandem-purification of BLOC-1(IsoB), all BLOC-1 subunits 
were detected. By size-exclusion chromatography analysis, BLOC-1(IsoB) was estimated to 
have a Stokes radius of ~89.Å, which is less than the Stokes radius of BLOC-1(IsoA). Dysbindin 
isoform B has a difference of 48 residues from dysbindin isoform A. It is unlikely that the 48 
residue difference between isoform A and B could be causing this difference of 9 Å. Instead, it is 
possible that residues in dysbindin isoform B that differ from dysbindin isoform A are causing 
the complex to form a more spherical shape, hence causing BLOC-1(IsoB) to elute in later 
fractions. This difference in conformation could mean that BLOC-1(IsoB) might have functional 
differences from BLOC-1(IsoA). Little is known about the function of dysbindin isoform B. 
More recently, the laboratory of  Qi Xu in China has published three studies focused on 
characterization of dysbindin isoform B. When GFP-tagged dysbindin isoforms were transfected 
into COS1 cells, the dysbindin isoform B was shown to form aggresomes at perinuclear regions 
whereas dysbindin isoforms A and C were diffused in the cytoplasm [15]. A mouse model was 
engineered to expressed the endogenous human dysbindin isoform B, and it was reported that 
dysbindin isoform B also aggregated in the neurons of these mice [16]. Lastly, in these mice that 
over-expressed human dysbindin isoform B, the expression of the other BLOC-1 subunits were 
decreased, and the subunits were found to be aggregated into deposits colocalized to dysbindin 
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isoform B [17]. As a result, they have suggested that dysbindin isoform B forms toxic 
aggregation that co-aggregates with BLOC-1 subunits, and in turn impairs the cognitive function 
of schizophrenia patients. The interpretation of these results should be approached with caution 
for two reasons. The first is the issue with the association between the gene encoding dysbindin, 
DTNBP1, and schizophrenia. As discussed in Chapter 1, DTNBP1 is no longer considered a top 
candidate gene for schizophrenia by many leading researchers in the field [18]. However, many 
groups still hold to the view that it is, even though the genetic studies no longer support their 
view. The second is that all these experiments were over-expressions of dysbindin isoform B. It 
can be argued that dysbindin isoform A and C did not aggregate when over-expressed, but as 
some of my results indicate, the complex that dysbindin isoform B forms may have a different 
shape than BLOC-1, which might make dysbindin isoform B more susceptible to aggregation. It 
should be noted that the study did find that over-expression of dysbindin isoform B affected 
expression of the other BLOC-1 subunits, further supporting the fact that dysbindin isoform B 
and the BLOC-1 subunits have an interaction. 
 Dysbindin isoform C, on the other hand, was not able to form a stable complex. Although 
dysbindin isoform C was able to directly interact with the same subunits as dysbindin isoform A, 
purification of the BLOC-1(IsoC) did not yield equal amounts of all the BLOC-1 subunits 
suggesting that a stable complex was not formed. It was previously shown that the coiled-coil 
region of dysbindin was enough to interact with pallidin, snapin, and muted [19], so it was not 
surprising that dysbindin isoform C, which has the coiled-coil region, was able to interact with 
pallidin, snapin and muted. The size-exclusion chromatography analysis made it clear that a 
BLOC-1(IsoC) was not forming a stable complex. In a recent study from Wei Li’s group, the 
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function of dysbindin isoform C was examined. In this study, they used the sandy mouse, which 
has a mutation in the gene encoding dysbindin, and the muted mouse, which has a mutation in 
the gene encoding muted. They showed by sedimentation velocity analysis, that the dysbindin 
isoform C was not co-sedimenting with known subunits of BLOC-1 [3]. Hence they concluded 
that dysbindin isoform C was not part of BLOC-1 and showed by immunoblot analysis that the 
band they identified as dysbindin isoform C was still expressed in the muted mouse. Because of 
these results, they argued that the muted was null for dysbindin isoform A, but not for dysbindin 
isoform C, and so could be used as a model to study the function of dysbindin isoform C 
specifically. They reported that analysis of the muted and sandy mouse suggests that dysbindin 
isoform C, but not A, regulates adult hippocampal neurogenesis in the dentate gyrus [3]. It is true 
that it is difficult to examine the functions of these different isoforms and that there is not a 
simple experimental setup to do so. However, in the experimental setup of this study there is a 
clear assumption that is not addressed. It is assumed that the different background strain of the 
sandy, in the DBA/2J background, and muted, in the CHMU/Le background, mouse strains were 
not causing the differences that they see. 
 Purification of BLOC-1 subunits with pallidin isoform 2 indicated that pallidin isoform 2 
is unable to form a stable complex. HIS-purification of these subunits was able to purify parts of 
subcomplex-2 (dysbindin, BLOS2, and snapin), but GST purification only purified 
subcomplex-2 and not pallidin isoform 2, suggesting that pallidin isoform 2 may have a weaker  
or transient interaction with subcomplex-2. The Y2H analysis showed that pallidin isoform 2 was 
not even able to interact with the subunits that pallidin isoform 1 interacted with. From these 
findings, combined with the previous report that only pallidin isoform 2 is expressed in human 
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brains, one might think that BLOC-1 may not form in the human brain. However, it has recently 
come to light that many of the reported results from the first author (Andrew R. Cullinane) of 
this study had been falsified [4, 20]. In light of this recent revelation, the findings from this 
report need to be taken with a extreme caution. It is likely that BLOC-1 does exist in the human 
brain as a stable complex with pallidin isoform 1. In fact, it is reported in a new database (The 
Human Protein Atlas) that the transcript and protein of pallidin isoform 1 is expressed in the 
human brain [21]. 
 Lastly, the BCAS4 protein was not able to replace the cappuccino subunit to form a stable 
complex. One possibility is that the BCAS4 protein is an interacting partner of the whole 
complex. However, in the previous study that used the BCAS4 protein as a bait, it was shown 
that the BCAS4 protein interacts with all the BLOC-1 subunits except cappuccino [7]. If the 
BCAS4 protein was just an interacting parter of the whole BLOC-1, cappuccino should also have 
been present. The other possibility is that the BCAS4 protein does form a complex with BLOC-1 
subunits, but requires additional subunits. In the proteomic study, there were four other protein 
encoded by the genes ATG4A, SRCIN1, PKD2, and LOH12CR1 that were also identified as 
interacting with the BCAS4 protein [7]. It is possible that the BCAS4 protein forms a complex 
with some of the BLOC-1 subunits in addition to one or more of these 4 proteins. Further 
analysis is required to address this question. 
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 Figure 5.1 Schematic of previously characterized human dysbindin isoforms A-C. 
Dysbindin is encoded by the gene DTNBP1 and has multiple splice variants. Dysbindin isoform 
A is the full-length form with 351 amino acids, and its transcript includes 10 exons. The 
transcript that encodes dysbindin isoform B has exons 1-9, but has an alternative sequence 
encoding alternative residues in the C-terminal (shown in red). The transcript encoding dysbindin 
isoform C is predicted to have a downstream start codon within exon 5 and as a result it includes 
parts of exon 5 and exons 6-10. There are two patients with Hermansky-Pudlak Syndrome type 7 
(HPS7) with nonsense mutations in the gene encoding dysbindin (location of the mutations are 
indicated green and purple). The sandy mouse has an in-frame deletion in the gene encoding 
dysbindin (location equivalent to the mouse gene indicated in blue). CC, predicted coiled coil 
region. 
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 Figure 5.2 Schematic of previously characterized human pallidin isoforms 1 and 2. Pallidin 
isoform 1 is encoded by the gene BLOC1S6, and is the full-length form with 172 residues. The 
transcript that encodes pallidin isoform 1 has 5 exons. A splice variant that only shares exon 2 
with the full-length form, encodes pallidin isoform 2, which has 101 residues. The residues in 
pallidin isoform 2 that differ from pallidin isoform 1 are represented by the red bars. There is one 
patient with Hermansky-Pudlak Syndrome type 9 (HPS9) reported to have a nonsense mutation 
in BLOC1S6 (location indicated in orange). CC, predicted coiled coil regions. 
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Figure 5.3 Schematic of BLOC-1(WT) expressed from a polycistronic plasmid. All eight 
subunits of BLOC-1 were expressed from a polycistronic plasmid. The pallidin subunit was 
fused with a HIS6- affinity tag on the N-terminal and the dysbindin subunit was fused with a 
GST-affinity tag on the C-terminal. Two subcomplexes have been described [13]: subcomplex-1, 
which includes pallidin, BLOS1, and cappuccino (shown in blue) and subcomplex-2, which 
includes dysbindin, snapin, and BLOS2 (shown in green). The other two subunits, muted (pink) 
and BLOS3 (orange) are thought not to be part of any subcomplex. 
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Figure 5.4 Expression of recombinant BLOC-1 subunits in E. coli. E. coli, transformed with a 
polycistronic plasmid that expresses all eight subunits of BLOC-1, was cultured in 2xYT media, 
and protein expression was induced with IPTG. Pelleted cells were obtained by centrifugation 
and boiled in the presence of SDS-PAGE sample buffer.  Immunoblot analysis was done to 
demonstrate that the bacteria expressed all eight subunits. E.coli with an empty vector was used 
as a negative control. The band labeled as “a” is a degradation product of Dysbindin-GST and 
likely is GST itself. The band labeled as “b” is likely a degradation product of HIS6-pallidin and 
is detected in the immunoblots for HIS6 and pallidin. The multiple bands labeled as “c” likely 
correspond to bacterial proteins cross-reacting with the anti-muted antiserum, which was  used 
without purification. 
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Figure 5.5 Coomassie Blue and immunoblot analysis of the BLOC-1 subunits after tandem 
purification (GST>HIS6). The purification of recombinant BLOC-1 was optimized using a 
tandem purification method (GST-purification followed by HIS-purification). E. coli, 
transformed with a polycistronic plasmid that expresses all eight subunits of BLOC-1, was 
cultured in 2xYT media and protein expression was induced with IPTG. Pelleted cells were lysed 
and the cleared lysates were incubated with glutathione-sepharose beads. Proteins were eluted 
and rebound to Talon resins. Proteins were eluted again and boiled in the presence of SDS-PAGE 
sample buffer. Coomassie Blue staining of the purified recombinant BLOC-1 shows 8 distinct 
bands. Each of the bands visible in the Coomassie was identified as one of the eight subunits of 
BLOC-1 by immunoblot analysis. a: GST degradation product of Dysbindin-GST (containing the 
GST moiety), which cross-reacted with several of the antibodies raised against GST-fusion 
proteins. b: degradation product of HIS6-pallidin. c: Dysbindin-GST. 
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Figure 5.7 Quantification of signal intensity of BLOC-1(IsoB) after GST-purification. 
BLOC-1(IsoA) and BLOC-1(IsoB) were purified on glutathione-sepharose beads. Protein levels 
of each subunit in the purified samples were analyzed by immunoblotting. The signal intensity of 
the bands from the immunoblots was quantified and background corrected. To quantify relative 
yields, the signal intensity of each subunit was divided by the signal intensity of the Dysbindin-
GST subunit. Then, these normalized ratios of each BLOC-1(IsoB) subunit were divided by the 
normalized ratios of the corresponding subunit of BLOC-1(IsoA). Bars and error bars represent 
means ± S.E.M. of 5 separate sets of GST-purifications. A one sample t-test was performed for 
each subunit. None of the tests reached statistical significance upon correction for multiple 
testing. 
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Figure 5.8 Quantification of signal intensity of BLOC-1(IsoB) after HIS6-purification. 
BLOC-1(IsoA) and BLOC-1(IsoB) were purified on the Talon resins. Protein levels of each 
subunit in the purified samples were analyzed by immunoblotting. The signal intensity of the 
bands from the immunoblots was quantified and background corrected. To quantify relative 
yields, the signal intensity of each subunit was divided by the signal intensity of the HIS6-
Pallidin subunit. Then, these normalized ratios of each BLOC-1(IsoB) subunit were divided by 
the normalized ratios of the corresponding subunit of BLOC-1(IsoA). Bars and error bars 
represent means ± S.E.M. of 5 separate sets of HIS6-purifications. A one sample t-test was 
performed for each subunit. None of the tests reached statistical significance upon correction for 
multiple testing. 
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Figure 5.9 Quantification of signal intensity of cappuccino from GST-purified 
BLOC-1(IsoA) and BLOC-1(IsoB). BLOC-1(IsoA) and BLOC-1(IsoB) were purified on 
glutathione-sepharose beads. Samples were incubated with Tobacco Etch Virus (TEV) protease 
and dialyzed to cleave the GST tag from dysbindin. After dialysis, the samples were incubated 
again with glutathione-sepharose beads to remove the GST tag. The resulting TEV-treated 
samples, together with control samples not treated with protease, were analyzed by 
immunoblotting using antibodies to cappuccino, BLOS1, and BLOS3. The signal intensities of 
the bands from the immunblots to cappuccino, BLOS3 and BLOS1 were quantified and each 
value background corrected. Because the GST tag was removed, the signal intensities of BLOS3 
and BLOS1 were used to normalize for relative yield. The signal intensity of cappuccino was 
divided by the averaged signal intensity of BLOS3 and BLOS1. The normalized cappuccino 
signal ratios were then divided by those of the undigested BLOC-1(IsoA). Bars and error bars 
represent means ± S.E.M. of 3 separate sets of GST-purifications. A one sample t-test was 
performed for cappuccino levels of BLOC-1(IsoB). *p<0.05. A Student’s t-test was performed 
for comparison of normalized cappuccino levels of BLOC-1(IsoA) + TEV versus BLOC-1(IsoB) 
+ TEV. ns, not significant. 
!  105
Figure 5.10 Quantification of signal intensity of BLOC-1(IsoC) after GST-purification. 
BLOC-1(IsoA) and BLOC-1(IsoC) were purified on glutathione-sepharose beads. Protein levels 
of each subunit in the purified samples were analyzed by immunoblotting. The signal intensity of 
the bands from the immunoblots was quantified and background corrected. To quantify relative 
yields, the signal intensity of each subunit was divided by the signal intensity of the Dysbindin-
GST subunit. Then, these normalized ratios of each BLOC-1(IsoC) subunit were divided by the 
normalized ratios of the corresponding subunit of BLOC-1(IsoA). Bars and error bars represent 
means ± S.E.M. of 5 separate sets of GST-purifications. A one sample t-test was performed for 
each subunit and p-values were corrected for multiple testing. Corrected p-values: *p<0.05, 
***p<0.001 
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Figure 5.11 Quantification of signal intensity of BLOC-1(IsoC) after HIS6-purification. 
BLOC-1(IsoA) and BLOC-1(IsoC) were purified on the Talon resins. Protein levels of each 
subunit in the purified samples were analyzed by immunoblotting. The signal intensity of the 
bands from the immunoblots was quantified and background corrected. To quantify relative 
yields, the signal intensity of each subunit was divided by the signal intensity of the HIS6-
Pallidin subunit. Then, these normalized ratios of each BLOC-1(IsoC) subunit were divided by 
the normalized ratios of the corresponding subunit of BLOC-1(IsoA). Bars and error bars 
represent means ± S.E.M. of 5 separate sets of HIS6-purifications. A one sample t-test was 
performed for each subunit and p-values were corrected for multiple testing. Corrected p-values: 
***p<0.001 
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 Figure 5.12 Yeast two-hybrid analysis of binary interactions between selected BLOC-1 
subunits and dysbindin isoforms B and C. Yeast cells were co-transformed with Gal4 DNA-
binding and activation domains alone (vector) or fused in-frame to the indicated human ORFs. 
Double transformants were first selected on minimal medium lacking leucine and tryptophan and 
then spotted onto planes containing the same medium (as a control) or selective medium also 
lacking histidine (HIS) and containing 5 mM 3AT. 
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Figure 5.13 Tobacco Etch Virus protease digestion of BLOC-1(IsoA), BLOC-1(IsoB) and 
BLOC-1(IsoC) after GST-purification. BLOC-1(IsoA), BLOC-1(IsoB) and BLOC-1(IsoC) 
were purified on glutathione-sepharose beads. An aliquot of each sample was boiled in the 
presence of SDS-PAGE sample buffer and the rest was incubated with Tobacco Etch Virus 
protease and dialyzed. The purified samples were re-incubated with the glutathione-sepharose 
beads to removed the GST tag. An aliquot of the digested samples was then boiled in the 
presence of SDS-PAGE sample buffer. Notice that the bands corresponding to dysbindin-GST 
from BLOC-1(IsoA), BLOC-1(IsoB), and BLOC-(IsoC) (arrows) had a shift in apparent 
molecular weight after digestion (arrowheads). 
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Figure 5.17 Representative immunoblot analyses of BLOC-1(WT) and BLOC-1(Iso2). The 
open reading frame (ORF) encoding pallidin isoform 1 was replaced with that encoding pallidin 
isoform 2, fused in frame with that encoding HIS6. Bacterial pellets from E. Coli transformed 
with this construct were examined by immunoblot analysis for the expression of BLOC-1 
subunits. BLOC-1(WT) and BLOC-1(Iso2) were purified by the GST tag alone, the HIS6 tag 
alone, and by both (GST>HIS6 tandem purification) and the representative immunoblots of those 
purified samples are shown above. *: The pallidin antibody (Monoclonal 2G5) recognizes an 
epitope that is missing from pallidin isoform 2. Dys-GST: Dysbindin-GST, HIS6-Pa: HIS6-
pallidin. 
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Figure 5.18 Quantification of signal intensity of BLOC-1(Iso2) after GST-purification. 
BLOC-1(WT) and BLOC-1(Iso2) were purified on glutathione-sepharose beads. Protein levels 
of each subunit in the purified samples were analyzed by immunoblotting. The signal intensity of 
the bands from the immunoblots was quantified and background corrected. To quantify relative 
yields, the signal intensity of each subunit was divided by the signal intensity of the Dysbindin-
GST subunit. Then, these normalized ratios of each BLOC-1(Iso2) subunit were divided by the 
normalized ratios of the corresponding subunit of BLOC-1(WT). Bars and error bars represent 
means ± S.E.M. of 5 separate sets of GST-purifications. A one sample t-test was performed for 
each subunit and p-values were corrected for multiple testing. Corrected p-values: ***p<0.001 
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Figure 5.19 Quantification of signal intensity of BLOC-1(Iso2) after HIS6-purification. 
BLOC-1(WT) and BLOC-1(Iso2) were purified on Talon resins. Protein levels of each subunit in 
the purified samples were analyzed by immunoblotting. The signal intensity of the bands from 
the immunoblots was quantified and background corrected. To quantify relative yields, the signal 
intensity of each subunit was divided by the signal intensity of the HIS6-Pallidin subunit. Then, 
these normalized ratios of each BLOC-1(Iso2) subunit were divided by the normalized ratios of 
the corresponding subunit of BLOC-1(WT). Bars and error bars represent means ± S.E.M. of 5 
separate sets of HIS6-purifications. A one sample t-test was performed for each subunit and p-
values were corrected for multiple testing. Corrected p-values: *p<0.05, **p<0.01, ***p<0.001 
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 Figure 5.20 Yeast two-hybrid analysis of binary interactions between BLOC-1 subunits and 
pallidin isoform 2. Yeast cells were co-transformed with Gal4 DNA-binding and activation 
domains alone (vector) or fused in-frame to the indicated human ORFs. Double transformants 
were first selected on minimal medium lacking leucine and tryptophan and then spotted onto 
planes containing the same medium (as a control) or selective medium also lacking histidine 
(HIS) and containing 5 mM 3AT. 
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Figure 5.21 Representative immunoblot analyses of BLOC1(-CNO) and BLOC-1(BCAS4). 
The open reading frame (ORF) encoding cappuccino was replaced with that encoding BCAS4. 
As a negative control, the ORF encoding cappuccino was removed. Bacterial pellets from E. Coli 
transformed with these constructs were examined by immunoblot analysis for the expression of 
BLOC-1 subunits. BLOC-1(WT), BLOC-1(-CNO), and BLOC-1(BCAS4) were purified by the 
GST tag alone and by tandem purification (GST>HIS6), and the representative immunoblots of 
those purified samples are shown above. 
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Figure 5.22 Yeast two-hybrid analysis of binary interactions between BLOC-1 subunits and 
theBCAS4 protein. Yeast cells were co-transformed with Gal4 DNA binding and activation 
domains alone (vector) or fused in-frame to the indicated full-length human ORFs. Double 
transformants were first selected on minimal medium lacking leucine and tryptophan and then 
spotted onto planes containing the same medium (as a control) or selective medium also lacking 
histidine (HIS) and containing 5 mM 3AT. 
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CHAPTER 6 
Analysis of critical residues of dysbindin for binding AP-3 
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ABSTRACT 
BLOC-1 is well described to have a physical interaction with another multimeric protein 
complex, Adaptor Protein (AP)-3.  A previous study reported that the dysbindin subunit of 
BLOC-1 is able to interact with AP-3. In this chapter I report the minimal region within 
dysbindin to bind AP-3. I used site-directed mutagenesis to identify the critical residues. 
Mutation of the critical residue in the context of the whole recombinant BLOC-1 disrupted 
binding to AP-3. 
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INTRODUCTION 
 Adaptor protein (AP)-3 is a heterotetrameic complex, which functions as a molecular 
sorting device that mediates the intracellular trafficking of proteins to lysosomes and related 
organelles (reviewed in [1]). AP-3 is composed of four subunits, δ, β3, µ3, and σ3 and has been 
described to interact with various proteins via different subunits (reviewed in [2]). One of these 
interactions is with BLOC-1 [3-7].  
  A physical interaction between BLOC-1 and AP-3 was initially observed by co-
immunoprecipitation of the endogenous complexes from HeLa cells and mouse liver [3], and the 
interaction has been reproduced in different tissues and cell lines [4-7]. Mutations of subunits in 
both complexes are associated with a rare autosomal recessive disorder called Hermansky -
Pudlak Syndrome (HPS) [8-13], and patients with HPS display oculocutaneous albinism and 
prolonged bleeding due to defective lysosome-related organelles. Mouse models with mutations 
in either complex also display HPS-like phenotypes (reviewed in [14]). Because BLOC-1 and 
AP-3 mutants share similar characteristics, it has been suggested that BLOC-1 and AP-3 work in 
the same machinery that controls protein sorting. However, the biological function of this 
interaction is still not clear. 
 Binding motifs for AP-1 [15-19], AP-2 [19-22], and AP-4 [23, 24] were previously 
described, but no such motif has been characterized in AP-3. A group in Japan reported that 
dysbindin specifically bound to AP-3, and that AP-3 recognized a minimal consensus sequence 
YXXØ in dysbindin, where Y is a tyrosine, Ø is a bulky hydrophobic residue and X represents 
any amino acid [7]. However, the YXXØ motif had been previously described as the binding 
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motif through which the other AP complexes interact with their cargoes and the interaction 
between AP complexes and cargoes via this motif has been characterized to be an weak 
interaction (reviewed in [25]). The interaction between BLOC-1 and AP-3, on the other hand, is 
not a weak or transient interaction as demonstrated by the previously mentioned studies [3-7], so 
it is unlikely that BLOC-1 is interacting with AP-3 via this motif only. Furthermore, the tyrosine 
of the YXXØ motif was mutated in a GST-dysbindin fusion protein and the mutated fusion 
protein was shown to still bind AP-3 [7]. Because of the concerns with analysis and 
interpretation of the data, I have sought to reanalyze the interaction between dysbindin and AP-3. 
 To identify the critical residues of dysbindin required to bind AP-3, I first used GST 
(glutathione S-transferase)-fusion proteins with different segments of dysbindin to delineate the 
minimum region of dysbindin for binding to AP-3. I then performed an alanine-scanning 
mutagenesis analysis of the delineated region to identify critical residue(s) of dysbindin required 
for binding to AP-3. These residue(s) in dysbindin were then mutated in the context of the whole 
BLOC-1 complex and the mutated BLOC-1 was examined for its ability to bind AP-3. 
!  125
EXPERIMENTAL PROCEDURES 
DNA constructs 
All of the plasmids used in the present study consisted of human cDNA sequences that were 
cloned in-frame into the EcoRI-SalI sites of pGEX-5X-1 (Amersham Biosciences) to generate 
GST-fusion proteins. The constructs that express GST-dysbindin fragments 181-351, 
181-351;Y215A, 181-258, and 181-246, and the GST-DBNDD2 protein were kindly provided by 
Verónica Cheli. The construct that expresses GST-dysbindin fragment 224-351, was kindly 
provided by Marta Starvcevic. 
Antibodies 
Monoclonal rabbit antibody to the µ3 subunit of AP-3 (clone: EPR16385) was purchased from 
Abcam and used at a concentration of 1:3,000. 
Site-directed mutagenesis 
To alter targeted residues within the C-terminal dysbindin fragment (181-351), mutagenic 
oligonucleotide primers were designed, ordered for synthesis (Eurofin) and used to change the 
codons of the targeted residues to those of alanine by site-directed mutagenesis using the 
QuikChange XL Site-Directed Mutagenesis Kit (Agilent Technologies). Mutagenesis was 
verified by DNA sequencing. The mutated sequence was digested and cloned in-frame into the 
EcoRI-SalI site of a new pGEX-5x-1 expression vector, to ensure that no unwanted mutations 
were introduced into the expression vector during the PCR amplification of the whole plasmid.  
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Production of GST-fusion proteins 
E.coli strain BL21 Star (DE3) (Invitrogen by Thermo Fisher Scientific) was transformed with the 
appropriate plasmid and cultured in 2xYT media (18g/l tryptone, 11g/l yeast extract, 5.6 g/l 
NaCl). At an optical density at 600 nm (OD600) of 0.6, protein expression was induced with 0.1 
mM isopropyl-beta-D-thiogalactopyranoside (IPTG) for 4 hours at 20°C. Pelleted cells, obtained 
by centrifugation at 6,000 x g for 15 mins, were homogenized in phosphate buffered saline 
(PBS) supplemented with 30 µl of protease inhibitor mixture (Sigma), and sonicated using a 
Branson Sonifier 450 (output #5, 50% duty cycle, 30 seconds on, 15 seconds off, 6 times). 
Appropriate amounts of triton X-100 were added to bring its concentration to 1% (w/v), and the 
homogenate was incubated in 4°C for 30 min. Following centrifugation at 6,000 x g for 15 mins, 
the cleared lysates were incubated with glutathione-Sepharose 4 Fast-Flow beads (GE Healthcare 
Life Sciences) for 1 h at 4°C. The beads were washed once with PBS with 1% (w/v) triton 
X-100, three times with 30 ml of PBS, and once with 0.1M Tris-HCl, pH 8.0. The proteins were 
eluted with 20 mM  glutathione in 0.1M Tris-HCl, pH 8.0. 
Tandem purification of the recombinant BLOC-1 is described in Chapter 5. 
GST-pulldown assay 
Frozen bovine brain was purchased from PelFreez. All purification steps were performed at 4°C. 
The bovine brain was cut into smaller pieces and as much white matter as possible was removed. 
The cut brain pieces (~260 g) were homogenized in Lysis Buffer [10mM Hepes, pH 7.4, 0.25 M 
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sucrose, 1 mM EGTA,  0.5 mM MgCl2, 1 mM DTT] supplemented with a protease inhibitor 
mixture (Sigma) using a tissue blender (3 x 15 s). The homogenate was centrifuged at 13,000 x g 
for 15 min, filtered through gauze, centrifuged at 13,000 x g for another 15 mins, and filtered 
through gauze again. The resulting supernatant was further centrifuged at 120,000 x g for 90 
mins to obtain cytosolic extract, which was stored at -80°C. Frozen bovine brain cytosol was 
thawed and diluted 1:1 (v/v) with diluting buffer [10 mM Hepes, pH 7.4, 150 mM KCl, 0.5mM 
MgCl2, 1mM EGTA, 1mM dithiothreitol] supplemented with a protease inhibitor mixture 
(Sigma) and centrifuged at 120,000 x g for 30 mins. GST-fusion proteins were immobilized onto 
15 µl of glutathione-Sepharose 4 Fast-Flow beads (GE Healthcare Life Sciences) washed, and 
then incubated with pre-cleared bovine brain cytosol for 1 hour at 4°C. The beads were washed 
three times with washing buffer [20mM Hepes, pH 7.4, 50 mM KCl, 1 mM EGTA, 0.5 mM 
MgCl2] containing 0.1% (w/v) Triton X-100 and once in washing buffer alone, and bound 
proteins were analyzed by SDS-PAGE, and immunoblotting as described in Chapter 5. To 
determine how much of the GST-fusion protein bound to the beads, the bound proteins were 
loaded onto a separate gel and stained with Coomassie-blue as described in Chapter 5. 
For quantitative analysis of protein expression levels, enhanced chemiluminescence signals were 
captured on the ChemiDoc Imaging System (Biorad) and digitally integrated using the National 
Institutes of Health Image Software (Image J, http://rsb.info.nih.gov/ij/). For the comparison of 
relative protein levels of AP-3 that bound to the GST-dysbindin fragments with a mutation in 
tyrosine 215, the mean pixel intensity was measured for each band using the same area for bands 
on the same membrane. The pixel intensity of the background was subtracted from the pixel 
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intensity of each band on the same membrane. To correct for loading, the background-corrected 
values of the blots were then divided by the background-corrected values of the Coomassie 
staining. The background- and loading-corrected values of AP-3 that bound to the GST-
dysbindin fragments with a mutation in tyrosine 215 were divided by the background- and 
loading-corrected values of AP-3 that bound to the GST-dysbindin fragment with no mutation in 
tyrosine 215. A one-sample t-test was performed using GraphPad Prism 5.0b (GraphPad 
Software) to determine statistical significance from the theoretical value of 1. 
Conservation analysis 
The level of conservation in the 181-258 residues of dysbindin across all available mammalian 
species in BLAST (Basic Local Alignment Search Tool) was assessed using the Scorecons server 
at http://www.ebi.ac.uk/thornton-srv/databases/valdarprograms/scorecons_server_help.html 
based on the equations described in [26].  
Secondary structure prediction 
The secondary structure predictions were done using the Network Protein Sequence @nalysis 
server at https://npsa-prabi.ibcp.fr/NPSA/npsa_seccons.html, and the methods, DSC, HNNC, 
MLRC, PHD, Predator, and SOPM.  
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RESULTS 
 
Mapping the minimal region required for dysbindin to bind AP-3 
 GST-fusion proteins of dysbindin fragments were purified and used to analyze binding to 
AP-3. The initial experiments done by a former postdoc (Verónica Cheli) revealed that the C-
terminal region (residues 181-351) of dysbindin was sufficient to bind AP-3 and that dysbindin 
paralogs (DBNDD1 and DBNDD2), which have conserved regions in the C-terminal of 
dysbindin, were unable to bind AP-3 (Fig. 6.1, lanes 4, 6, and 7). To further narrow down the 
region within dysbindin required for AP-3 bind, I analyzed GST-dysbindin fragments with small 
increments of the C- and N-terminal removed. GST-dysbindin fragments with residues 181-246 
and 224-351 were no longer able to bind AP-3, whereas GST-dysbindin fragment with residues 
181-258 was still able to bind AP-3 (Fig. 6.1 lanes 10, 11, and 12). This suggested that there was 
a critical region in the N-terminus between amino acid 181-224 and another critical region in the 
C-terminus between amino acid 246-258.  
 Because of the previous study that reported that tyrosine 215 was critical for binding to 
AP-3, this tyrosine was analyzed. Mutation of the tyrosine decreased AP-3 binding, but did not 
prevent binding completely (Fig. 6.1, lane 5, Fig. 6.2), indicating that the tyrosine 215 is an 
important residue, but not critical for binding to AP-3. Additionally, the tyrosine motif, YLQI, 
was added to the dysbindin paralog DBNDD2, but it was still unable to bind AP-3 (Fig. 6.1, lane 
8), again suggesting that the YXXØ motif is not the minimal consensus sequence in dysbindin to 
bind AP-3. The summary of these results is in Figure 6.3. 
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Site-directed mutagenesis of dysbindin residues 181-258 
 To select which residues to target first, the amino acid sequence of the human dysbindin 
was aligned with those of dysbindin orthologs from mouse, cattle, and frog as well as those of 
the dysbindin paralogs, DBNDD1 and DBNDD2. Residues conserved in all species, but not in 
the paralogs, were selected for mutagenesis. Selected residues that were in close proximity with 
each other were mutated together, and if no other selected residue was close, the residue was 
mutated alone. Some of GST-dysbindin fragments with these mutations had a decrease in 
binding to AP-3, but none of them had complete disruption of binding (Fig. 6.4, 6.5). Because 
the critical residues were not identified by this first method, the amino acid sequences of 
dysbindin orthologs from all mammals were aligned, and the degree of conservation of the 
residues was estimated (Fig. 6.15A). The residues with 100% conservation were then selected for 
mutagenesis (Fig. 6.6-Fig. 6.12). Two regions were found to be critical for binding AP-3. The 
first region included 6 residues from 206-212, excluding residue 208. Only when the six residues 
(DM-QYLS) were mutated, binding to AP-3 was completely disrupted (Fig. 6.6, lane 9, Fig. 
6.10, lane 6, Fig. 6.11, lane 6, and Fig. 6.13, lane 11). The six residues were individually mutated 
in different GST-dysbindin fragments, but these GST-dysbindin fragments were still able to bind 
AP-3 (Fig. 6.10). Even when four or five of these residues were mutated together, the mutated 
GST-dysbindin fragment still bound AP-3 (Fig. 6.11, Fig. 6.13). The second region was closer to 
the C-terminus of the delineated region. GST-dysbindin fragments with mutations in residues 
250-255 had a decrease in binding to AP-3 (Fig. 14, lanes 6 and 7), but when the leucine 256 was 
mutated, there was a complete loss of binding to AP-3 (Fig. 6.12, lane 7, Fig. 6.14, lane 9). 
Analysis of the critical residues is summarized in Figure 6.15C, and D. Lastly, the critical leucine 
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256 residue was mutated in the context of the recombinant BLOC-1. The wild-type BLOC-1 was 
able to bind AP-3 (Fig. 6.16 lane 6) whereas the mutant BLOC-1 was no longer able to bind (Fig. 
6.16, lane 7). This suggests that dysbindin is the only subunit of BLOC-1 that binds AP-3 and 
that the mutation of the leucine 256 residue of dysbindin is able to disrupt binding between 
BLOC-1 and AP-3, at least in vitro. 
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DISCUSSION 
 Initial mapping of the minimal region of dysbindin required for binding to AP-3 
delineated a large fragment spanning from residues 181-258. It was initially puzzling as to why 
such a large fragment was required. After analysis with smaller GST-dysbindin fragments, it 
seemed that two regions were required for binding. A small fragment of dysbindin with residues 
181-246 was no longer able to bind AP-3, suggesting that there were residues between 246-258 
critical for binding AP-3. Additionally, a dysbindin fragment with residues 224-351 no longer 
bound. This fragment contained the residues 246-258, but was still unable to bind AP-3, 
suggesting that there was a second region critical for binding between residues 181-224. Site-
directed mutagenesis analysis made it clear that there were in fact two areas with critical residues 
to bind AP-3. The first was a group of 6 residues (DM-QYLS) between residues 206-212 and the 
second was a single leucine 256 residue. Analysis of the predicted secondary structure of 
residues 181-258 of dysbindin showed that these two critical areas lie in predicted helices 
separated by a region of coils (Fig. 6.14B), suggesting that these two critical areas could be 
brought closer by a bend in the coiled region, and thereby both interacting with AP-3. Because 
only one critical residue was identified, there was no motif that could be described. 
 A single mutation of the critical leucine 256 residue in the recombinant BLOC-1 was 
shown to disrupt binding to AP-3 completely. Assuming that mutation of this residue disrupts the 
interaction of BLOC-1 and AP-3 also in vivo, a model organism with a mutation in this leucine 
can be used to study the exact biological function that interaction between BLOC-1 and AP-3 
has. Further analysis is required to address this point. 
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Figure 6.1 GST-pulldown assay of AP-3 with GST-dysbindin fragments and paralogs. GST-
fusion proteins were purified, rebound to glutathione-Sepharose 4 Fast-Flow beads, and 
incubated with bovine brain cytosol. Beads were washed, and bound proteins were denatured by 
heating in the presence of SDS and analyzed by SDS-PAGE. AP-3 bound to the GST-fusion 
proteins was detected by immunoblot analysis using an antibody to its µ3 subunit. GST-fusion 
proteins bound to the beads were detected by Coomassie staining. Notice that the GST-dysbindin 
fragments 224-351 and 181-246 (lanes 10, and 12) and dysbindin paralogs (lanes 6, and 7) were 
unable to bind AP-3, but the fragment 181-258 (lane 11) was. *proteins from the bovine brain 
cytosol with affinity to the beads. 
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 Figure 6.2 Mutation of tyrosine 215 to alanine decreased binding of dysbindin to AP-3. 
GST-pulldown analysis was performed using a GST-dysbindin fragment with a mutation in the 
tyrosine residue 215. AP-3 bound to the GST-fusion proteins was detected by immunoblot 
analysis using an antibody to its µ3 subunit, and band intensities were analyzed by densitometry. 
Square dots represent relative levels of AP-3 bound to the GST-dysbindin fragment 
(181-351;Y215A). Normalization of the data is explained in greater detail under Experimental 
Procedures. A one-sample t-test was done to determine statistical significance. *p<0.05. 
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 Figure 6.3 Schematic of GST-fusion proteins used to map the minimum residues of 
dysbindin required to bind to AP-3. The black bar represents the full-length dysbindin, which 
has 351 residues. Above the bar, the location of the previously described tyrosine-containing 
motif is marked (YLQI). The blue bars represent GST-dysbindin fragments that have been tested 
to bind AP-3. The residues included in each dysbindin fragment are on the left of the bars. The 
magenta bars represent GST-fusion proteins of the dysbindin paralog DBNDD2 and the teal bar 
represents the GST-fusion proteins of the dysbindin paralog DBNDD1. The asterisk identifies the 
location of mutations within the fragments. Ability of the fragment to bind AP-3 is on the right. 
+, AP-3 bound to GST-fusion protein.  ↓, decreased amounts of AP-3 bound to GST-fusion 
protein. -, no AP-3 bound to GST-fusion protein. 
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Figure 6.4 Site-directed mutagenesis of conserved dysbindin residues between 181-258 in 
human, mouse, cattle, and frog, but not in dysbindin paralogs. Conserved residues were 
mutated into alanine in GST-dysbindin fragments (181-351). GST-fusion proteins with mutations 
were purified, rebound to glutathione-Sepharose 4 Fast-Flow beads, and incubated with bovine 
brain cytosol. Beads were washed, and bound proteins were denatured by heating in the presence 
of SDS and analyzed by SDS-PAGE. AP-3 bound to the GST-fusion proteins was detected by 
immunoblot analysis using an antibody to its µ3 subunit. GST-fusion proteins bound to the beads 
were detected by Coomassie staining. Notice that all the GST-dysbindin fragments with 
mutations were able to bind AP-3 (lanes 6-10), but some had decreased binding to AP-3 (lanes 6, 
8, and 9). *proteins from the bovine brain cytosol with affinity to the beads. 
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Figure 6.5 Site-directed mutagenesis of conserved dysbindin residues between 181-258 in 
human, mouse, cattle, and frog, but not in dysbindin paralogs. Conserved residues were 
mutated into alanine in GST-dysbindin fragments (181-351). GST-fusion proteins with mutations 
were purified, rebound to glutathione-Sepharose 4 Fast-Flow beads, and incubated with bovine 
brain cytosol. Beads were washed, and bound proteins were denatured by heating in the presence 
of SDS and analyzed by SDS-PAGE. AP-3 bound to the GST-fusion proteins was detected by 
immunoblot analysis using an antibody to its µ3 subunit. GST-fusion proteins bound to the beads 
were detected by Coomassie staining. Notice that all the GST-dysbindin fragments with 
mutations were able to bind AP-3 (lanes 6-9), but one had decreased binding to AP-3 (lane 9). 
*proteins from the bovine brain cytosol with affinity to the beads. 
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Figure 6.6 Site-directed mutagenesis of dysbindin residues 181-258 conserved in mammals. 
Conserved residues were mutated into alanine in GST-dysbindin fragments (181-351). GST-
fusion proteins were purified, rebound to glutathione-Sepharose 4 Fast-Flow beads, and 
incubated with bovine brain cytosol. Beads were washed, and bound proteins were denatured by 
heating in the presence of SDS and analyzed by SDS-PAGE. AP-3 bound to the GST-fusion 
proteins was detected by immunoblot analysis using an antibody to its µ3 subunit. GST-fusion 
proteins bound to the beads were detected by Coomassie staining. Notice that the GST-dysbindin 
fragment in lane 9 did not bind AP-3 and the GST-dysbindin fragments in lanes 8 and 10 had 
decreased binding to AP-3.*proteins from the bovine brain cytosol with affinity to the beads. 
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Figure 6.7 Site-directed mutagenesis of dysbindin residues 181-258 conserved in mammals. 
Conserved residues were mutated into alanine in GST-dysbindin fragments (181-351). GST-
fusion proteins were purified, rebound to glutathione-Sepharose 4 Fast-Flow beads, and 
incubated with bovine brain cytosol. Beads were washed, and bound proteins were denatured by 
heating in the presence of SDS and analyzed by SDS-PAGE. AP-3 bound to the GST-fusion 
proteins was detected by immunoblot analysis using an antibody to its µ3 subunit. GST-fusion 
proteins bound to the beads were detected by Coomassie staining. Notice that the GST-dysbindin 
fragments in lanes 8 and 9 had decreased binding to AP-3. *proteins from the bovine brain 
cytosol with affinity to the beads. 
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Figure 6.8 Site-directed mutagenesis of dysbindin residues 181-258 conserved in mammals. 
Conserved residues were mutated into alanine in GST-dysbindin fragments (181-351). GST-
fusion proteins were purified, rebound to glutathione-Sepharose 4 Fast-Flow beads, and 
incubated with bovine brain cytosol. Beads were washed, and bound proteins were denatured by 
heating in the presence of SDS and analyzed by SDS-PAGE. AP-3 bound to the GST-fusion 
proteins was detected by immunoblot analysis using an antibody to its µ3 subunit. GST-fusion 
proteins bound to the beads were detected by Coomassie staining. Notice that in lanes 7 and 8 are 
replicates of the same GST-dysbindin fragments, which had decreased binding to AP-3. *proteins 
from the bovine brain cytosol with affinity to the beads. 
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Figure 6.9 Site-directed mutagenesis of dysbindin residues 181-258 conserved in mammals. 
Conserved residues were mutated into alanine in GST-dysbindin fragments (181-351). GST-
fusion proteins were purified, rebound to glutathione-Sepharose 4 Fast-Flow beads, and 
incubated with bovine brain cytosol. Beads were washed, and bound proteins were denatured by 
heating in the presence of SDS and analyzed by SDS-PAGE. AP-3 bound to the GST-fusion 
proteins was detected by immunoblot analysis using an antibody to its µ3 subunit. GST-fusion 
proteins bound to the beads were detected by Coomassie staining. Notice that the GST-dysbindin 
fragment in lanes 6-9 all bound AP-3. *proteins from the bovine brain cytosol with affinity to the 
beads. 
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Figure 6.10 Site-directed mutagenesis of individual residues mutated in the GST-fragment 
that did not bind AP-3. Residues were mutated into alanine in GST-dysbindin fragments 
(181-351). GST-fusion proteins were purified, rebound to glutathione-Sepharose 4 Fast-Flow 
beads, and incubated with bovine brain cytosol. Beads were washed, and bound proteins were 
denatured by heating in the presence of SDS and analyzed by SDS-PAGE. AP-3 bound to the 
GST-fusion proteins was detected by immunoblot analysis using an antibody to its µ3 subunit. 
GST-fusion proteins bound to the beads were detected by Coomassie staining. The GST-
dysbindin fragment in lane 6 is the same fragment that did not bind in Figure 6.6, lane 9. Notice 
that the GST-dysbindin fragments in lanes 7-12 did not have disrupted binding to AP-3. *proteins 
from the bovine brain cytosol with affinity to the beads. 
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Figure 6.11 Site-directed mutagenesis of residues in the GST-fragment 181-258. Conserved 
residues were mutated into alanine in GST-dysbindin fragments (181-351). GST-fusion proteins 
were purified, rebound to glutathione-Sepharose 4 Fast-Flow beads, and incubated with bovine 
brain cytosol. Beads were washed, and bound proteins were denatured by heating in the presence 
of SDS and analyzed by SDS-PAGE. AP-3 bound to the GST-fusion proteins was detected by 
immunoblot analysis using an antibody to its µ3 subunit. GST-fusion proteins bound to the beads 
were detected by Coomassie staining. The GST-dysbindin fragment in lane 6 is the same 
fragment that did not bind in Figure 6.6, lane 9. Notice the GST-dysbindin fragments in lanes 
8-11 had decreased binding to AP-3, while GST-dysbindin fragments in lanes 7 and 12 were not 
able to bind AP-3.*proteins from the bovine brain cytosol with affinity to the beads. 
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Figure 6.12 Site-directed mutagenesis of residues of GST-fragment 181-258. Residues were 
mutated into alanine in GST-dysbindin fragments (181-351). GST-fusion proteins were purified, 
rebound to glutathione-Sepharose 4 Fast-Flow beads, and incubated with bovine brain cytosol. 
Beads were washed, and bound proteins were denatured by heating in the presence of SDS and 
analyzed by SDS-PAGE. AP-3 bound to the GST-fusion proteins was detected by immunoblot 
analysis using an antibody to its µ3 subunit. GST-fusion proteins bound to the beads were 
detected by Coomassie staining. Notice the GST-dysbindin fragments in lanes 6, 7, and 9 were 
not able to bind AP-3 and all have a mutation in the leucine 256 residue. *proteins from the 
bovine brain cytosol with affinity to the beads. 
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Figure 6.13 Summary of the critical residues of dysbindin fragment 181-258. GST-dysbindin 
fragments with mutations in the N-terminal were reanalyzed. Previously purified GST-dysbindin 
fragments were rebound to glutathione-Sepharose 4 Fast-Flow beads, and incubated with bovine 
brain cytosol. Beads were washed, and bound proteins were denatured by heating in the presence 
of SDS and analyzed by SDS-PAGE. AP-3 bound to the GST-fusion proteins was detected by 
immunoblot analysis using an antibody to its µ3 subunit. GST-fusion proteins bound to the beads 
were detected by Coomassie staining. Notice that the GST-dysbindin fragments in lanes 5-10 had 
reduced binding to AP-3 and the GST-dysbindin fragment in lane 11 was not able to bind AP-3. 
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Figure 6.14 Summary of the critical residue of dysbindin fragment 181-258. GST-dysbindin 
fragments with mutations in the C-terminal were reanalyzed. Previously purified GST-dysbindin 
fragments were rebound to glutathione-Sepharose 4 Fast-Flow beads, and incubated with bovine 
brain cytosol. Beads were washed, and bound proteins were denatured by heating in the presence 
of SDS and analyzed by SDS-PAGE. AP-3 bound to the GST-fusion proteins was detected by 
immunoblot analysis using an antibody to its µ3 subunit. GST-fusion proteins bound to the beads 
were detected by Coomassie staining. Notice that the GST-dysbindin fragments in lanes 8 and 9 
were not able to bind AP-3 and have a mutation in the leucine 256 residue. 
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Figure 6.15 Analysis of the dysbindin residues 181-258 and summary of the scanning 
alanine mutagenesis analysis. (A) Sequence conservation levels of the dysbindin residues 
181-258 across mammals. The degree of conservation was calculated as described in 
Experimental Procedures. (B) The predicted secondary structure of dysbindin residues 181-258. 
H, Helix. C, coil. ?, undetermined. (C) Summary of the scanning alanine mutagenesis analysis of 
dysbindin residues 181-258. Letters highlighted in grey represent residues unimportant for 
binding to AP-3. Letters highlighted in yellow represent residues that affected binding to AP-3, 
but were not critical. The letter highlighted in red represents the critical residue that when 
mutated had no binding to AP-3. The letters not highlighted were not tested. The black bar 
represents the GST-dysbindin fragment (181-258) that is able to bind AP-3. The first red bar 
represents the GST-dysbindin fragment (224-351) and the second red bar represents the GST-
dysbindin fragment (181-246), both of which were not able to bind AP-3. (D) Schematic of 
constructs that had decreased binding to AP-3 (Blue) or no binding to AP-3 (Red). Dots represent 
no mutation. Letters present the residues that were mutated into alanine. 
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 Figure 6.16 Alanine mutagenesis of leucine (residue 256) in recombinant BLOC-1. The 
leucine residue (256) was mutated to an alanine in the dysbindin subunit of recombinant 
BLOC-1. Tandem purified recombinant BLOC-1 was rebound to glutathione-Sepharose 4 Fast-
Flow beads, and incubated with bovine brain cytosol. Washed beads were denatured by heating 
in the presence of SDS and analyzed by SDS-PAGE. AP-3 bound to the GST-fusion proteins was 
detected by immunoblot analysis using an antibody to its µ3 subunits. Proteins bound to the GST 
beads were detected by Coomassie staining. The subunits of BLOC-1 were detected by 
Coomassie staining (arrowheads). Notice that the mutated recombinant BLOC-1 in lane 7 was 
not able to bind AP-3. *proteins from the bovine brain cytosol with affinity to the beads. 
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Chapter 7 
CONCLUSIONS 
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 The overall goal of this dissertation was to characterize the possible function(s) of 
BLOC-1 in the mouse brain (discussed in Chapters 2, 3, and 4) and the interaction with 
alternative subunit(s) as well as with other similar complexes in vitro (discussed in Chapters 4, 
and 5). 
 Studies investigating BLOC-1 function in brain have thus far focused on its role in an 
otherwise normally developed brain. However, my results discussed in Chapters 2 and 3 suggest 
that BLOC-1-deficient mice present with subtle defects during brain development. I have found 
that, in these mice, the cell bodies of CA1 hippocampal neurons appeared less compacted and 
uncharacteristically distributed compared to wild-type mice. By postnatal day 45 this 
malformation was no longer present, suggesting a delay in this brain area development, which 
might have profound ramifications in hippocampal adult functions. In a normally developing 
hippocampus, CA1 develops first and is important that this process occurs in a proper manner, as 
it will, in turn, influence the development of other hippocampal regions such as the dentate 
gyrus. I would like to speculate that this early defect elicited by lack of BLOC-1 may prevent the 
proper delivery of those signals from CA1 necessary for proper development of the dentate 
gyrus, resulting in the observed defects in dendritic arborization of granule cells. In the long 
term, such maldevelopment might be the underlie cause of the behavioral abnormalities observed 
in BLOC-1-deficient mice, particularly the memory defect(s) [1]. Electrophysiological 
experiments to assess the hippocampal circuit(s) are required to further characterize how this 
developmental delay affects the internal wiring of the hippocampus as well as its communication 
with other brain areas. 
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 Sexual dimorphism of the brain is well characterized, but the exact mechanism(s) of these 
differences is still under investigation. My analysis of the BLOC-1-deficient mice has shown that 
there are sex differences in these mice whereby female mice appeared to be “protected” from the 
effects of BLOC-1 deficiency on the brain early postnatal development. As I was completing the 
experimental work for this dissertation, a paper characterizing another BLOC-1-deficient mouse 
model reported that an important developmental change in the subunit composition of the N-
methyl-D-aspartate (NMDA) receptor was disrupted in the hippocampus of male mice, but not 
female mice [2], further providing evidence of the females being protected from some of the 
consequences of BLOC-1 deficiency. Most sex differences in physiology and disease are 
regulated by sex hormones secreted by the gonads (reviewed in [3]). However, some of the genes 
on the sex chromosomes independent of the gonads can also cause some sex differences, 
particularly during development before the emergence of sex-specific patterns from sex 
hormones (reviewed in [4]). To determine whether the “protective” effects seen in BLOC-1-
deficient females derives from the sex hormones or genes on the sex chromosomes, we could 
consider crossing the BLOC-1-deficient mice with the four-core genotype (FCG) model 
(reviewed in [54]). There are two critical genetic components in the FCG model: the first is a 
deletion of the testis-determining gene Sry on the Y chromosome [6]; the second is an insertion 
of the Sry transgene onto an autosomal chromosome making the mouse a ‘gonadal male’ [7]. 
This model allows XX and XY mice to be gonadal females and males. These manipulations 
allow for the production of four genotypes: the first two are a XY male, a normal male mouse, 
and a XY female, which has the deletion in the Sry gene making the mouse gonadal female; the 
second two are a XX female, a normal female mouse, and a XX male, which has the insertion of 
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the Sry transgene making the mouse gonadal male. This cross can be used to isolate the gonadal-
determined effects from those due to the sex chromosomes. 
 Initial studies on dysbindin functions(s) in the brain were largely focused on its role in 
neurons, in part based on an early paper describing a neuronal-specific expression of dysbindin 
in human brain [8]. However, other studies have shown that dysbindin, and as extension 
BLOC-1, is also expressed in glial cells [9,10]; in particular, dysbindin has been found highly 
enriched in Müller cells [11], which are a subtype of radial glia specifically found in the retina. 
One of the abnormalities I have observed in the BLOC-1-deficient male brains at P1 was a clear 
disruption of the radial glial cell processes, which likely caused the anomalous cell distribution 
observed in the hippocampal cell layer. It appears that BLOC-1 may play an important 
physiological role in glial cells, not just in neurons, which deserves to be further examined. 
 In Chapters 4, I reported deficits in the dendritic processes of granule cells in the 
BLOC-1-deficient dentate gyrus. Similarly, previous work in our lab as well as others [9,12] 
showed deficits in neurite outgrowth in primary cultures of BLOC-1-deficient hippocampal 
neurons. These findings altogether strongly suggest a role of BLOC-1 in process elongation. 
However, the mechanism by which lack of BLOC-1 affects the development of these processes 
is still largely unknown. Recently, BLOC-1 has been shown to play a role in the formation of 
recycling endosomes, which diverts cargoes towards the cell surface [13]. It is possible that in 
certain hippocampal cell types, BLOC-1 is involved in the formation of recycling endosomes 
that carry small GTPases, such as Rab10 and Rab11, which have been reported to play a role in 
dendritic arborization [14,15]. Furthermore, in a study that used a data-mining approach to rank 
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candidate protein-binding partners of BLOC-1, it was reported that Rab11 might be a top 
candidate among 68 potential binding proteins [16]. 
 Alternatively spliced forms of dysbindin have been reported, and as shown in Chapter 5, 
the alternatively spliced variant dysbindin isoform B was able to replace the full-length form and 
assemble into a complex with the other BLOC-1 subunits. The exact biological function of this 
complex that contains dysbindin isoform B is unclear. Although it is possible that dysbindin 
isoform B may be able to compensate for the absence of the full-length form of dysbindin, it 
cannot be ruled out that BLOC-1 with dysbindin isoform B may have novel function(s). The 
second isoform, dysbindin isoform C, on the other had, was unable to replace the full-length 
form and assemble into a complex with the other BLOC-1 subunits. At this point, it is still 
unknown whether dysbindin isoform C even has a biological function independent of BLOC-1.  
Thus, more work is required to understand the function of these alternatively splice variants. 
However, it is clear that future studies of dysbindin should take into consideration these 
alternatively splice variants when interpreting the results. 
 As mentioned in Chapter 6, binding motifs have been characterized for AP-1 [17-21], 
AP-2 [21-24], and AP-4 [25,26], where as no binding motif has been identified for AP-3. In an 
attempt to discover a motif for AP-3, I identified the critical residues for binding between AP-3 
and BLOC-1. As described in Chapter 6, I have found two critical regions for binding, but only 
one critical residue. As a result, it was impossible to characterize a binding motif for AP-3. The 
question remains whether all other binding partners of AP-3 interact with AP-3 through these two 
critical regions like BLOC-1, or this method of interaction is unique to BLOC-1. To address this 
question, the critical residues of other AP-3 binding partners should be analyzed. 
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